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INTRODUCTION 
Advances in sequencing and microarray technology have enabled the progress 
of systematic and thorough genome-wide analyses to assess the localisation and 
frequency of different variants in the human genome. For more than a decade, 
single nucleotide polymorphisms (SNPs) have been a focus of interest for 
human geneticists. As a result, a large number of studies have associated these 
single nucleotide variants with variability in different human phenotypes1. In 
addition to SNPs, short (one to a few tens of base pairs) insertions and deletions 
of genomic DNA sequences (commonly referred to as indels) are also present in 
the human genome2–4. During the last decade, knowledge concerning even 
longer unbalanced gains and losses of genomic DNA sequences (conventionally 
called copy number variants or CNVs) has massively increased and has also 
excited the interest of human geneticists5–8. DNA copy number variation is a 
type of genetic variation that may increase the copy number of a particular 
DNA segment from the normal two copies per diploid genome to more than two 
copies (e.g., duplication or triplication) or decrease it to less than two copies 
(deletion).  
Although the extensive presence of CNVs in the human genome has been 
studied for the last decade5,6, the reported extent of copy-number variation in 
different species and individual genomes differs greatly7,9. CNV lengths in the 
human genome typically range from a few kilo-bases to several mega-bases and 
are estimated to cumulatively cover at least 5% of the human genome7,9–11. In 
many instances, CNVs have been shown to play an important role in different 
human phenotypic traits, and their association with disease susceptibility has 
been increasingly recognised.  
Alterations in DNA copy-number are the most likely cause of many genetic 
disorders (hereditary and de novo) and play an important role in tumourigenesis 
and susceptibility to common diseases. The identification of such disease-
associated altered regions in the DNA provides valuable information about the 
genes involved in the disease and presents one step towards understanding the 
underlying molecular mechanisms. However, computational methods that can 
help investigators find and prioritise variants obtained from different experi-
ments are needed. 
In the review of literature of the current thesis, I will provide a short 
overview of copy number variants in the human genome, including how CNVs 
are discovered with current microarray-based methods, their known effects on 
human phenotypic traits or disease susceptibility and what is known about their 
population genetics. 
In the results and discussion I will describe and discuss a few methods 
developed for CNV calling and phasing. I will also describe and discuss the 
inheritance of copy number variants and their allelic variability.  
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REVIEW OF LITERATURE 
1. Copy number variation in the human genome 
DNA copy number variation is a type of genetic variation in which case the 
number of allelic copies of a particular region of a genome is altered from its 
normal ‘state’. In the non-repetitive portion of the human genome, the normal 
haploid copy number is one – one copy of each sequence per chromosome. 
Accordingly, the normal diploid copy number in humans is two – one copy 
inherited from both parents. A copy number variant (CNV) can result from 
either a loss of copies (most often called a deletion) or gain of copies (called a 
duplication or amplification). Different deletion and duplication variants are 
illustrated in Figure 1.  
 
Figure 1. Copy number variants in a diploid genome. Close-up picture of a 
chromosomal region that contains a CNV (the green region).Whereas the grey regions 
are present in normal copy numbers (haploid copy number of one: cn=1; diploid copy 
number of two: CN=2) in individuals A-F, the green region has different haploid and 
diploid copy numbers in different individuals.  
CNVs in the human genome range from tens of bases to several mega-bases12,13. 
One of the largest sequencing-based studies estimated that the median CNV size 
in the human genome was 729 bp, with mean of 8 kb11. Although the abundant 
presence of CNVs in healthy individuals has been known for many years5,7,14, 
the reported number and extent of CNVs has been wide-ranging and has varied 
from a few to up to a few thousand per diploid genome9,15. CNVs are 
cumulatively estimated to cover 1–18% of the DNA sequence in the human 
3
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diploid genome7,10,15–17. Often, these discrepancies are due to differences in the 
technology and the experimental or computational methods used; the broad 
consensus is that CNVs cover approximately 5–10% of human genomic DNA 
sequences9,10,18,19. Thus, CNVs cover approximately 0.3–0.8% of the genome in 
every individual9,20, corresponding to 9–24 Mb of DNA sequence.  
Although copy number variants occur virtually everywhere in the human 
genome, there are many CNV hotspots where CNVs occur more frequently. 
This is well illustrated by an autosomal map of long (>100 kb) CNVs from 
approximately 2500 individuals from ethnically diverse populations (Figure 2). 
 
Figure 2. Autosomal landscape of large CNVs. Large (>100 kbp) copy number variants 
in the human genome based on analysis of 2493 individuals. Observed duplications are 
depicted in blue, heterozygous deletions in orange and homozygous deletions with 
black rectangles. Chromosomes are drawn to their size scale (outside tick marks 
indicate 10 Mb), and CNVs observed more frequently than ten times for a given locus 
are cropped (based on Itsara et al., 2009). 
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Many CNVs in different individuals have identical recurrent breakpoints. 
However, some CNVs have slightly different breakpoints, often depending on 
the mechanism responsible for the introduction of the CNV20.  
 
1.1 Mechanisms of CNV formation 
There are three primary classes of known mechanisms that create CNVs. A 
large number of copy number variants that often have recurrent breakpoints in 
the same locus arise by non-allelic homologous recombination (NAHR) 
between segmental duplication or low-copy repeats16,21. NAHR can result in 
deletions and duplications as well as inversions and translocations depending on 
the location and orientation of the interacting homologous sequences22,23. Inter-
chromosomal and intra-chromosomal (inter-chromatidal) NAHR events can 
facilitate both deletions and duplications, whereas intra-chromatidal events 
result in only deletions24,25. Non-homologous end joining (NHEJ) is the most 
common DNA repair mechanism in mammalian cells; this mechanism involves 
ligating together any two broken DNA ends and does not require homologous 
sequences, although it has been shown that the presence of terminal micro-
homologies also facilitates NHEJ26. NHEJ can result in small scale non-
recurrent deletions and translocation rearrangements with minimal to no 
junction homology21. Microhomology-mediated mechanisms (collectively re-
ferred to as MMRDR) include microhomology-mediated break-induced repli-
cation (MMBIR), break-induced serial replication slippage (BISRS), and fork 
stalling and template switching (FoSTeS)22,27–29. These mechanisms are 
consistent with a common hypothesis that the leading/lagging strand primer/ 
polymerase disengages from its template upon replication fork stalling, trans-
locates and then re-associates (probably using short microhomology at the 3′ 
end) to another available template/replication fork in physical proximity and 
resumes replication27,30. This phenomenon can result in non-recurrent deletions, 
duplications or complex rearrangements, including triplications and inversions28. 
Considering these most prevalent mutational mechanisms, it would be 
intuitive to propose that deletions and duplications are not generated and do not 
occur at equal rate in the human genome because some mechanisms give rise to 
only deletions. It has been estimated that deletions and duplications are likely to 
be generated in proportions of approximately 2:1 to 3:1, with the ratio varying 
widely from region to region17. Based on empirical genome-wide studies we 
know that large deletions and duplications occur with an approximately 2:1 
ratio23.  
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2. Microarray-based CNV detection 
Despite the decreasing costs of whole-genome sequencing (WGS) and whole-
exome sequencing (WES), microarrays are still extensively used in genetic 
studies of disease susceptibility and clinical diagnostics. Although sequencing-
based applications have great deal of potential and enable investigators to 
interrogate almost every base pair in the studied genomes, both experimental 
and computational methods to infer copy number variants from sequencing data 
are still being developed and standardised31,32. Microarrays still represent the 
gold standard for both genotyping and CNV calling, especially in case of rare 
variants. Furthermore, increased sample sizes and improved analytical tools have 
stimulated what could be called a ‘microarray-based genotyping renaissance’. 
DNA copy number detection using microarray techniques is an indirect 
method to estimate diploid copy numbers of the studied DNA at pre-defined 
genomic loci by interrogating the sample with specifically designed or selected 
microarray probes. Briefly, the genomic DNA of interest is amplified and 
hybridised to a solid chip matrix carrying locus-specific capture probes. These 
probes most often are 25–60 bp in length and include in situ synthesised or 
spotted oligonucleotide molecules that are complementary to a specific unique 
sequence in the human genome assembly. In the case of array-CGH 
(microarray-based comparative genomic hybridisation), an additional reference 
DNA (often a cytogenetically controlled DNA or pool of DNAs) is co-
hybridised to the same array. After the hybridisation process in which amplified 
and fluorescent dye-labelled genomic sequences are specifically bound to 
capture probes, the arrays are washed to remove any non-specifically bound 
material and the quantity of the specifically hybridised DNA is estimated by 
measuring the fluorescent signal intensity (FSI) for each capture probe by 
scanning the microarray chip.  
FSIs from microarray probes exhibit dosage-dependent responses to 
alterations in the DNA copy number up to a certain level. Thus, the more copies 
of a certain sequences there are in the studied sample, the higher the corres-
ponding probe’s FSI level will be. In the case of array-CGH, two different 
fluorescent dyes are used for labelling – one to label the studied DNA and one 
to label the reference DNA. In the case of SNP genotyping microarrays, two 
different dyes are used to label different alleles of the bi-allelic SNP variants 
interrogated33,34. The most commonly used dyes for labelling are fluorescent 
cyanine-3 and cyanine-5 (abbreviated Cy3 and Cy5, respectively). These two 
fluorescent dyes are excited at different wavelengths and are quantified by a 
two-channel microarray scanner33. 
Because only pre-defined regions of the genome can be investigated with 
this method, CNV detection relies on the array design (i.e. how many probes are 
used and how these probes are distributed across the chromosomes). Therefore, 
as a rule of thumb (and quite intuitively), the use of more probes to cover all 
chromosomes uniformly results in a more accurate and higher resolution CNV 
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profile. It has been shown that the differences between platforms are more 
pronounced for short CNVs, whereas the differences resulting from genotyping 
platform largely disappear for larger (>500kb) CNVs16. In their high resolution 
study, Conrad et al. used custom-designed array-CGH arrays carrying 42 
million oligonucleotide probes that covered the assayable portion of the genome 
with median spacing of 56 bp9. Currently (Anno Domini 2015), top-notch geno-
typing microarrays have been produced with as many as 4.3 million probes 
(Illumina HumanOmni5Exome, www.illumina.com) and often additionally 
carry non-polymorphic probes to uniformly interrogate CNVs in the human 
genome. For example, the Affymetrix Genome-Wide Human SNP Array 6.0 
includes approximately 946 thousand CNV probes, with 200 thousand of such 
probes targeting common CNP loci and an additional 744 thousand probes 
evenly spaced along all of the chromosomes (www.affymetrix.com). 
In addition to high density and coverage, one obvious advantage of SNP 
genotyping arrays over array-CGH is the identification of allele-specific infor-
mation34,35. In addition to SNP genotype calling, the simultaneous measurement 
of total and allele-specific FSI makes it possible to detect both copy number 
changes and copy number neutral events, such as loss-of-heterozygosity (LOH).  
Known problems with genotyping arrays are their higher intrinsic variability 
caused by the PCR-based approach used to amplify the studied genomic 
material and the optimisation of these platforms for SNP variant calling (i.e., 
oligonucleotide design and the hybridisation chemistry/conditions used) rather 
than for CNV detection33,36. Consequently, these confounding factors can 
increase the proportion of false positive (region incorrectly called a variant) and 
false negative (undetected true variant) CNV calls if not properly taken into 
account. A relatively high rate of false positive and false negative findings has 
raised important concerns regarding the suitability of microarray-based copy 
number detection for clinical diagnostics applications. Although microarrays are 
suitable for CNV screening, reliable assays that provide clear and high quality 
results of measurable significance are required in a clinical diagnostics set-up. 
Moreover, false findings should be minimal and their rate should be accurately 
predictable37,38. 
 
2.1 Nature and principles of SNP genotyping microarray data 
Aside from the experimental microarray assay set-up, copy number detection 
for the studied sample can be quite complicated and cannot be regarded as an 
easy task. The reason for this is that even though the underlying biological 
nature of DNA copy numbers is always discrete (i.e., in one cell, genomic DNA 
copy number in a certain genomic region always corresponds to a certain non-
negative integer), the measured FSIs of the studied and reference DNA material 
from the microarray experiment most often come from a mixture of cells. Thus, 
these FSI values are continuous variables with a considerable amount of non-
biological variance and comprehensive and precise computational and statistical 
4
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methods are required to estimate the DNA copy number for different loci and to 
confidently detect CNVs34. 
As the first step in in silico copy number analysis, FSIs for all probes are 
organised by their genomic coordinates and normalised. For arrayCGH, 
logarithmic FSI ratios of the studied and reference DNA are used to infer 
CNVs9,20,39. For SNP genotyping arrays, FSIs from both channels (denoted ܺ 
and ܻ values and representing different SNP alleles usually indicated as alleles 
A and B) for the studied DNA are normalised against a panel of reference 
samples34,40,41. For the ith probe on the microarray, the total normalised 
logarithmic FSI (aka the Log R ratio or LRR) is calculated as follows: 
 
ܮܴܴ௜ = logଶ ൬
ܴ௜݋ܾݏ݁ݎݒ݁݀
ܴ௜݁ݔ݌݁ܿݐ݁݀൰ 
 
where ܴ௜݋ܾݏ݁ݎݒ݁݀ = 	 ௜ܺ + ௜ܻ  measures the total combined signal intensity of 
two FSI channels and ܴ௜݁ݔ݌݁ܿݐ݁݀ is measured from a set of ‘normal’ reference 
samples. 
 
Several adjacent positive or negative LRR values that significantly deviate from 
the expected value of zero corresponding to the most frequent diploid copy 
number of two observed in most loci for most individuals can be indicative of 
copy number gain (i.e., duplication and triplication) or loss (i.e., hetero- or 
homozygous deletion). 
Another relevant measure – the B allele frequency (BAF) is the normalised 
measurement of the relative FSI ratio corresponding to the B and A alleles: 
 
ܤܣܨ௜ = 	൞
0,	if 	ߠ௜ < 	ߠ௜	AA
0.5(ߠ௜ − ߠ௜	AA)/(ߠ௜	AB − ߠ௜	AA),	if	ߠ௜	AA ≤ ߠ௜ < ߠ௜	AB
0.5 + 0.5(ߠ௜ − ߠ௜	AB)/(ߠ௜	BB − ߠ௜	AB),	if	ߠ௜	AB ≤ ߠ௜ < ߠ௜	BB
1,	if 	ߠ௜ ≥ 	ߠ௜	BB
 
 
where the ith SNP-specific theta-value ߠ௜ = arctan( ௜ܺ/ ௜ܻ)/(ߨ/2) refers to the 
relative allelic signal intensity ratio and where ߠ௜	AA, ߠ௜	AB, and ߠ௜	BB	are the 
theta values for three canonical two-letter genotype clusters generated from a 
large set of reference samples42. This transformation from theta to BAF values 
adjusts for different characteristics of each probe so that the BAF values for 
different SNPs are comparable to each other41. A few examples of LRR and 
BAF values for normal, deletion and duplication CNVs are depicted in Figure 3. 
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Figure 3. Examples of plots with different LRR and BAF values (and corresponding 
SNP genotypes) for normal (diploid copy number of two – CN=2), heterozygous 
deletion (CN=1), homozygous deletion (CN=0 with ‘null’ alleles) and duplication 
(CN=3) copy number variants. 
 
2.2 Computational methods for CNV detection 
A naïve method for copy number variant detection is to identify genomic 
regions where the consecutive microarray probes demonstrate LRR values that 
significantly deviate from the expected LRR value (corresponding to a diploid 
copy number of two). This approach is often called the ‘fixed threshold method’ 
in the pertinent literature43–46. The problem with this simple method is that 
threshold-based methods have limited specificity (i.e., many false CNV calls are 
made) and sensitivity (i.e., many true CNVs are missed) because microarray 
FSIs exhibit considerable variance due to technical reasons that are often 
specific for each assay and probe, resulting in a high rate of false positive and 
negative findings47. 
More advanced methods were developed to overcome these problems by 
considering the intrinsic variance of microarray assays. Some methods consider 
the variance across all microarray probes (‘information-lending’ methods)48,49 or 
take advantage of a permutation procedure to find a better balance between the 
false positive and false negative findings within each assay47,50,51. If reference 
data are available (e.g., healthy individuals typed on the same platform), it is 
possible to consider the estimated FSI distribution for each microarray probe 
and to separately calculate a specific threshold for each probe33. These methods 
are one step forward compared to the naïve method and allow for the estimation 
of the proportion of false positive and negative CNV regions to decrease their 
proportion in the called CNVs. 
Additionally, several more sophisticated methods for CNV calling have been 
developed to date41. Hidden Markov model (HMM) and Bayesian methods are 
frequently used for CNV calling from high-density microarray data. Most of 
these methods use LRR values for CNV detection. A few algorithms use LRR 
and BAF values together and some also include user-specified or automatically 
16 
estimated experiment-related parameters. Hidden states in HMM represent the 
actual underlying copy number that is estimated by considering FSI and often 
also reflect other relevant measures. For example QuantiSNP – one of the first 
tools developed for CNV calling from SNP genotyping microarray data – uses 
an Objective-Bayes-HMM approach and simultaneously incorporates the LRR 
and BAF as well as a (fixed) value for the expected frequency of the B allele for 
all microarray probes in a HMM framework52. Another popular algorithm 
(PennCNV) uses the total diploid copy number specific and probe distance-
dependent transition probabilities in its HMM state-transition matrix, which is a 
more realistic model for the state transition between different diploid copy 
numbers in genomic DNA. PennCNV incorporates additional sources of 
relevant data to achieve finer breakpoint mapping and improve a posteriori 
CNV validation, including optionally population-specific values for the expected 
frequency of the B allele for each SNP and the distance between adjacent 
probes42.  
To diminish the rate of false positive findings, additional filtering steps are 
often applied to raw CNV calls. For example, very short predicted CNVs that 
are especially enriched in false positives or CNVs with low confidence metrics 
are often excluded33,34. Additionally, considering only CNVs detected by more 
than one algorithm can effectively minimise the proportion of false positive 
calls53–55. 
 
 
3. CNVs in health and disease 
The widespread distribution of CNVs in the human genome suggests that they 
play an important role in different human phenotypic traits, including disease 
susceptibility8,56. As many as 13% of the RefSeq genes cumulatively overlap 
with CNVs9, and CNVs have been demonstrated to have a direct impact on the 
gene expression of the encompassed or nearby genes57,58. CNVs can have 
functional and phenotypic consequences by changing gene expression patterns 
or altering the coding sequences of these genes. 
 
3.1 Genomic impact of CNVs 
Both deletion and duplication variants can act as loss-of-function (LoF) variants 
by simply disrupting coding sequences9. Heterozygous deletion variants (i.e., if 
one haplotype has been deleted, but the other haplotype is still present) can 
unmask other functional variants or even recessive deleterious mutations in the 
remaining haplotype59. Shorter intragenic CNVs can also generate novel genes 
and transcripts by fusing coding regions from different genes or by deleting 
exons of existing genes11,29. 
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Another obvious mechanism through which CNVs can effect on phenotypic 
traits is gene dosage60. Copy number variants encompassing dosage-sensitive 
genes or their regulatory regions can directly or through positional effects result 
in over- or under-expressed genes and consequent disparity in the corresponding 
phenotypes41. CNVs can also induce changes in DNA methylation with 
functional and phenotypic consequences61. 
Copy number variants can cumulatively (‘genomic burden’) or in combination 
with other variants (‘two-hit’ model) alter human phenotypes and cause 
sporadic or Mendelian and complex disease62. In contrast, it has been shown 
that there are approximately 100 genes in humans that can be completely or 
partially deleted without producing any apparent trait or disease consequences2,13. 
 
3.2 Associated trait and disease phenotypes 
The following three categories of genes are often enriched for copy number 
variants in healthy individuals: a) genes involved in extracellular biological 
processes and immunity (e.g., cell adhesion, cell recognition, signalling and 
immune response); b) genes involved in environmental response functions (e.g., 
sensory perception) and c) retrovirus- and transposition-related protein coding 
genes9,18,62. Additional known examples of normal phenotypical variability 
include CNVs associated with salivary amylase production5,7,63, red-green colour 
vision64–66, testosterone excretion level67 and rhesus blood group sensitivity68.  
CNVs have also been associated with several Mendelian or common disease 
phenotypes and infectious diseases69–74. Furthermore, it has been shown that 
newly arisen de novo copy number variants (germline mutations present in the 
offspring but not in the parents) can cause a variety of different diseases19,75. 
Examples of known CNV-driven disease associations include HIV infection 
susceptibility76,77, haemophilia A78, Parkinson’s disease79,80, Alzheimer’s 
disease81–83, obesity84–86, schizophrenia87–90, susceptibility to autism spectrum 
disorders91–95, systemic lupus erythaematosus96, psoriasis97,98 and other immune 
system-related diseases99,100. As with dominant de novo and recessive disease-
causing SNP variants, de novo copy number alterations alone and in combi-
nation with inherited CNVs can be responsible for more severe clinical 
phenotypes101 or cause sporadic disease75,102.  
The penetrance is nearly complete for some copy number variants84,89,95,103–
106; however, this is not the case for most CNV loci (especially for 
duplications)89,107–110. Possible reasons include epigenetic modifications, other 
genetic variants in the vicinity, modifier genes, regulatory elements (reviewed 
by Cooper et al.)111 and potentially alternative allelic copies present within the 
CNV regions.  
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4. Population genetics of CNVs 
Deleterious CNVs that predispose individuals to severe phenotypes are to some 
extent most likely to occur under purifying selective pressure18,112. This 
reasoning is supported by the observation that CNVs overlap with genes and 
other functional elements (e.g., enhancer regions and ultra-conserved elements 
such as exons in genes involved in RNA processing and introns or nearby genes 
involved in the regulation of transcription and development) less frequently in 
the human genome than could be expected to occur by chance7,113,114. In their 
high resolution study of HapMap individuals, Conrad et al. reported that the 
strongest negative selection was observed for exonic CNVs, followed by 
intronic and then intergenic CNVs9. 
Considering the frequency distribution of copy number variants in outbred 
populations, CNVs have clear tendency towards a lower frequency of variant-
carrying haplotypes20. Approximately 50% of all observed CNVs are singletons 
or are observed at very low frequency9,16,115. Indeed, CNV frequency has been 
shown to be strongly negatively correlated with CNV gene density and size 
(i.e., CNVs larger than 100 kb are rare, whereas common CNVs tend to be 
relatively small (<10 kb))10,16. Similarly, common CNVs usually harbour fewer 
genes than rare CNVs which can be relatively gene-rich. On the population 
level approximately 65–80% of individuals carry at least one CNV that is at 
least 100 kb in size and variants larger than 500 kb are present in 5–10% of 
individuals. In contrast, very large copy number variants (>1 Mb) are relatively 
rare and observed in only 1–2% of individuals on the population level16,62.  
Most CNV loci in the human genome can be explained by normal and 
simple deletion- and duplication-carrying haplotypes. As expected, deletion-
carrying haplotypes have been observed 1.3–2.2 -fold more frequently than 
duplication-carrying haplotypes in both microarray- and sequencing-based CNV 
studies11,20. An analysis of 849 whole genomes sequenced by the 1000 Genomes 
Project showed that there were simple deletion-carrying haplotypes in 55% of 
all detected CNVs; simple duplication-carrying haplotypes were found in 29% 
of CNVs and multi-allelic CNVs with three or more different segregating 
haplotypes (i.e., normal, deletion-carrying, and duplication-carrying haplotypes) 
were found in 16% of CNVs, thereby demonstrating that a considerable pro-
portion of such multi-allelic loci exist in the human genome116. It should be 
noted that the term ‘multi-allelic’ in the context of CNVs can be confusing 
because it is commonly used to note the fact that different types of copy number 
variants (i.e., deletion, duplication, triplication, etc.) segregate in the same 
region at the population level. 
Compared to frequency-matched SNP variants, ‘bi-allelic’ CNVs with 
normal and deletion- or normal and duplication-carrying haplotypes exhibit 
greater population stratification39. Additionally, bi-allelic copy number poly-
morphisms (CNPs – CNVs with a frequency ≥1%) show a strong correlation 
with flanking bi-allelic SNP genotypes. Furthermore, deletion variants can be 
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tagged more efficiently than duplications. In a study by Handsaker et al., 
duplication and multi-copy CNPs with a MAF >10% showed an almost uniform 
distribution of imputation correlation (r2) values between 0–1, whereas in 
another study, only 40% of duplication CNVs showed a high correlation (r2>0.8) 
with neighbouring SNPs39,116. This discrepancy could be due to allelic 
heterogeneity in proximity to the duplicated CNV or the fact that the transposed 
duplications are actually located farther away from the SNPs being tested for 
LD9,39,116. 
 
 
5. Haplotype and allelic variability in CNV regions 
It has been somewhat disregarded that in addition to variable copy numbers, the 
allelic composition (i.e., the actual DNA sequence) can differ slightly from 
copy to copy (Figure 4). In CNV studies published to date, only dichotomous 
conditions (i.e., gain or loss7, estimated total number of copies on two homo-
logous chromosomes (0, 1, 2, 3, 4, etc.)73,74,108,117 or the continuous normalised 
microarray intensity data57,115,118) have been considered.  
A few studies have demonstrated that in addition to CNV detection it is also 
possible to infer and output the total allelic composition for each SNP marker 
(called the ‘CNV genotype’ or ‘CNV-based SNP genotype call’) within indi-
viduals’ CNV regions using SNP genotyping arrays52,119,120. Similar to two-letter 
genotypes (e.g., ‘AA’ or ‘AB’ or ‘BB’), these null, mono-, tri- and tetraploid 
genotypes (e.g., ‘–‘, ‘A’, ‘AAB’ and ‘AABB’, respectively) are inferred from 
the B allele frequency (BAF) data for each SNP variant and represent the total 
allelic composition from both homologous chromosomes in the studied 
individual52,121,122. When these SNP-based CNV genotypes (i.e., the exact allelic 
composition within the CNV region) are considered, it is possible to infer the 
haplotypic phase of the allelic copies within each copy number variable region – 
a problem that was well defined for trisomic chromosomes by Clark and 
colleagues123.  
The correct phase information has been shown to be important for SNP 
variants124–126. Therefore, it is important to know, how exactly the allelic copies 
of a DNA sequence are distributed on different haplotypes on two sets of 
chromosomes within a CNV region8,127. The ability to phase and differentiate 
between normal haplotypes and CNV-carrying haplotypes with different allelic 
composition and to determine their parental origin would enable new, possibly 
more powerful association analyses with human disease traits128,129.  
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Figure 4. Haplotypes with slightly different allelic copies in a duplication CNV 
region. Haplotype-informative SNP genotypes in a duplicated region that are 
polymorphic between normal or duplication-carrying haplotypes and that can be used 
for phasing of given normal and CNV-carrying haplotypes are indicated with dashed 
rectangles. 
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AIMS OF THE PRESENT STUDY 
In the era of high-throughput genetics and genomics, bioinformatics and 
statistical tools are required for the critical interpretation of thousands or even 
millions of parallel experiments and to help draw the correct conclusion(s) from 
these experiments. The present thesis aimed to find and develop statistical and 
computational tools and methods for DNA copy number variant calling and 
analysis from DNA microarray data. 
 
The main research aims of the thesis were as follows: 
 
1. To develop a statistical framework for CNV detection from human 
chromosome X-specific microarrays (Ref. I) 
 
2. To develop a computational pipeline for CNV calling from whole-genome 
SNP genotyping microarray data (Ref. II–IV) 
 
3. To develop a computational method for phasing of normal and variant-
carrying haplotypes within CNV regions in families (Ref. II and IV) 
 
4. To study and describe the transmission and allelic variability of CNV 
haplotypes (Ref. II and IV) 
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RESULTS AND DISCUSSION 
1. Statistical method for detecting copy number variants 
from a chromosome X-specific microarray (Ref. I) 
Prior to any analysis of interesting copy number variants (i.e., association 
analysis, experimental CNV validation, breakpoint refinement, and functional 
consequences), the variants have to be detected from the raw data. For this, 
special statistical tools and methods are required. 
For the first practical application, we developed a computational workflow 
to detect copy number variants from a chromosome X-specific microarray 
containing 558 probes spanning almost the entire chromosome (with median 
spacing of 238 kb) and 111 control probes representing all autosomal chromo-
somes and chromosome Y. This single-channel array platform was developed 
in-house to screen patients with idiopathic mental retardation (MR). For the first 
step in CNV calling, microarray signals were transformed to the logarithmic 
scale and normalised between the arrays with respect to the median of: a) all 
fluorescent signal intensity (FSI) values or b) autosomal control probe-specific 
FSIs from microarrays included in the analysis. This was necessary because the 
absolute FSI values from different microarrays often varied several fold, and 
between-array normalisation enabled comparisons between FSI values from 
different microarrays. Next, the average and 90% tolerance interval values 
(TI90%) were calculated for each microarray probe using the data from the 
control panel containing FSIs from 5–15 cytogenetically controlled and 
phenotypically normal individuals. This step was performed separately for the 
male and female control panels. 
To discover possible CNVs, FSI values for the studied individuals were 
compared to the calculated 90% upper and lower tolerance interval values. 
Regions with two or more adjacent probes deviating in the same direction were 
marked as putative copy number variants and visually inspected from the FSI 
plots (Figure 5c and d). Theoretically, such criteria would have resulted in a 
false positive proportion of 0.5%. Empirically, we calculated the false positive 
rate of 1% on average and 3% in the worst case scenario when comparing 
normal females against the panel of normal females (and male to males).  
In practice, if no more than 10–20 probes deviated from the expected FSI 
values in a particular array-MAPH experiment, single probe alterations that 
might otherwise be interpreted as false positives were often further investigated, 
allowing smaller deletions or duplications to be detected or rejected.  
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Figure 5. Different samples analysed on a chromosome X-specific single-channel 
microarray. Normal male individual (A) and normal female individual (B) compared 
to a panel of healthy female controls illustrate how one copy of chromosome X (male, 
XY) compares to two copies of the chromosome (female, XX). The examples show 
individuals carrying a deletion (C) and duplication (D) CNV detected by the array-
MAPH method. 
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Although the chromosome X-specific array platform and related methods 
functioned quite robustly, the production and usage of this array was dis-
continued. New emerging computational methods developed for microarray-
based genome-wide SNP genotyping platforms provided much higher 
resolution and more sensitive detection of CNVs. 
 
 
2. Computational pipeline for CNV calling from SNP 
genotyping microarray data (Ref. II–IV) 
Maintaining a good balance between false positive and false negative findings is 
nearly always a challenging task. Different scientific questions and analyses 
might prioritise one or the other, often with a resulting trade-off between 
specificity and sensitivity.  
Because SNP genotyping arrays were first developed and optimised for SNP 
genotyping rather than genome-wide CNV detection and calling, CNVs detected 
from the SNP genotyping arrays include a considerable amount of false positive 
findings. To control the proportion of such false positive CNVs and to avoid 
possible false associations and/or interpretations in any downstream analyses, 
we developed a CNV calling pipeline for this application that combined two 
different CNV calling algorithms and a few additional QC steps in addition to 
standard quality control and filtering steps. As CNV calls from only one 
algorithm can include a large number of false positive calls, considering CNVs 
called by more than one independent algorithm will help decrease the number 
of false positive CNVs. 
For each studied individual, CNV calling was performed in parallel with the 
QuantiSNP and PennCNV programs. These initial raw CNV calls were further 
merged as intersections; only CNVs that were called by both algorithms for the 
same individual in the same genomic loci were considered for most analyses. 
To achieve unambiguous results in downstream analyses, only CNVs that were 
similarly called (same type of overlapping copy number change – gain or loss) 
were considered in Ref. IV. We used population-specific B allele frequency 
reference files (PFB-file) for different datasets in PennCNV, because this 
approach seemed to provide higher sensitivity in CNV calling and more accurate 
CNV start and end coordinates. Separate raw calls in relevant CNV regions 
from both algorithms were studied either manually (Ref. II and Ref. III) or 
programmatically (Ref. IV) to avoid false negative findings in individuals 
without ‘called-by-both-programs’ CNVs (either in studied cases and healthy 
controls or family members) resulting from our conservative calling metho-
dology. Additionally, we used breakpoints inferred by one single CNV calling 
program rather than the QuantiSNP-PennCNV intersection coordinates for 
experimental validations and other analyses that required CNV breakpoint 
coordinates because our CNV merging procedure systematically underestimated 
CNV size and therefore could possibly have provided incorrect starting and 
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ending positions. We used QuantiSNP coordinates (as described in Ref. II and 
Ref. III) because, in our hands, this algorithm gave more accurate breakpoint 
estimates than PennCNV. Discrete CNV regions (CNVRs) were defined by 
merging overlapping (≥1 bp) CNVs across all individuals in a study group as 
described previously7,130. 
For additional filtering steps, we filtered out very short putative CNVs and 
CNVs that contained only a few microarray probes. CNVs that had low log 
Bayes Factor (LBF) values (representing QuantiSNP confidence estimates for 
CNV calls) were also filtered out. If raw data were available, putative CNV 
regions were confirmed or omitted by visually inspecting the LRR and BAF 
plots for the CNV regions (as described in Ref. II and Ref. IV). We also filtered 
out CNV regions where any member of the corresponding family had any 
unclear raw CNV calls (‘called-by-one-program’) when working with family 
data (Ref. IV). 
 
 
3. Computational method for phasing normal and  
variant-carrying haplotypes within CNV regions  
(Ref. II and IV) 
Considering only CNVs called by two algorithms (and excluding CNV regions 
with inconclusive raw calls) provided good quality data that we further used to 
study how exactly new CNVs emerged and how existing CNVs were 
transmitted from parents to offspring. To accomplish this objective, we developed 
an algorithm that could computationally differentiate and phase normal and 
variant-carrying haplotypes within CNV regions in nuclear families based on 
genotyping microarray data.  
Our algorithm works by examining adjacent regular two-letter and null, 
mono-, tri- or tetraploid CNV genotypes (described earlier) in each family 
member in a CNV region present in any member of the corresponding family 
(Figure 6). Our algorithm uses copy number variant calls, user-defined family 
structure and informative genotypes that are polymorphic between the parents 
to phase the allelic composition within each copy number variable region in the 
studied families by deterministically testing all possible molecular haplotypes 
and their transmission according to the Mendelian inheritance scenarios in the 
studied CNV locus in a given family. If there is more than one child in the 
studied family, all children will be considered simultaneously in this step. 
Finally, our algorithm will select these normal and/or CNV-carrying haplotypes 
and transmission scenarios that can unambiguously explain the allelic content 
for every member of the corresponding family for each CNV locus. If it is not 
possible to explain the allelic composition in the offspring by Mendelian 
transmission scenarios of parental haplotypes, non-Mendelian scenarios –  
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Figure 6. Computational 
phasing of normal and  
CNV-carrying haplotypes.  
A putative de novo CNV region 
where Child 1 has inherited the 
normal haplotype from the mother 
and a deletion-carrying haplotype 
from the father. The other child 
(Child 2) has inherited normal 
haplotypes from both parents.  
In Child 1, both normal and 
deletion-carrying haplotypes are 
already inherently ‘phased’ (A). 
By considering the haplotypes 
and genotypes observed in the 
mother, Child 2 and the father, 
finding the exact haplotypes 
transmitted from both parents is 
intuitively and computationally 
very straightforward (B and C).  
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de novo deletion or duplication events and uniparental isodisomy/hetero-
disomy – are considered. In the presence of informative genotypes between 
parental haplotypes, our algorithm can also determine on which parental chromo-
some the mutation occurred (e.g., inter- or intra-chromosomal duplication). If 
there are no haplotype-informative markers within a CNV region and the 
simplest haplotypes and Mendelian inheritance scenarios do not explain the 
allelic composition in all family members, it is not possible to determine a 
single set of correct haplotypes and inheritance scenarios and several equally 
possible haplotypes and Mendelian and/or non-Mendelian transmissions are 
suggested as the result. 
 
 
4. Transmission and allelic variability  
of CNV-carrying haplotypes (Ref. II and IV) 
It is often important to identify which parent transmitted a certain variant (e.g., 
a putatively disease-causing CNV). Additionally, it is useful to understand how 
the variant of interest segregates within the corresponding family and whether 
the other affected or unaffected siblings have inherited the same variant and 
alleles (as described in Ref. II). In the case of de novo variants that are not 
directly inherited but have often emerged in parental germline cells, it might be 
important to elucidate whether the mutation occurred on the maternal or 
paternal chromosomes.  
To solve these questions, we used our phasing algorithm to resolve the 
normal and CNV-carrying haplotypes in trios or larger nuclear families based 
on genotype and copy number estimates from SNP microarray data. By 
studying 34 Estonian families (22 mother-father-child trios and 12 families with 
multiple siblings) and 30 HapMap Yoruban (YRI) trios, we discovered that it 
was computationally possible to unambiguously determine and phase the 
underlying normal and CNV-carrying parental haplotypes in vast majority 
(94%) of CNV regions and follow their transmission in offspring (Ref. IV). We 
observed that haplotype phasing was more efficient in CNV regions where only 
one CNV-carrying haplotype was present in one of the parents, resulting in a 
single or very few equally possible Mendelian and/or non-Mendelian trans-
mission scenarios. In comparison, when de novo CNVs or multiple CNV-
carrying haplotypes were present in the parents (especially duplication-carrying 
haplotypes), two or more equally possible haplotype combinations/transmission 
scenarios were often plausible (Ref. IV). 
 
4.1 Transmission of normal and CNV-carrying haplotypes within 
CNV regions in nuclear families (Ref. IV) 
We further analysed CNV regions that could be unambiguously phased in 
Estonian and HapMap YRI families and counted the number of transmission 
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events of normal or CNV-carrying haplotypes from the parents carrying a CNV. 
CNV-carrying haplotypes were observed in the offspring slightly less frequently 
than expected by random Mendelian inheritance. To further investigate this 
phenomenon, we analysed the transmission of deletion and duplication-carrying 
haplotypes in the combined dataset while also considering CNV length. 
Although this analysis revealed small deviations from the expected Mendelian 
transmission rate of 50% for both deletions and duplication in nearly all CNV 
length intervals, the previously observed differences were mainly driven by the 
under-transmission of short (<10 kb) deletion-carrying haplotypes in the 
HapMap dataset.  
Although these CNVs in the HapMap dataset were validated by other 
independent means, it is possible that these short under-transmitted CNVs 
contained proportionally more false positive CNV calls (either cell-line artefacts 
of actually incorrect CNV calls) that could not be transmitted and therefore 
appeared to be under-transmitted. However, a similar tendency was observed 
for longer (>10 kb) deletion-carrying haplotypes in both studied cohorts. Such 
bias might be expected in the case of some high penetrance CNVs associated 
with severe disease phenotypes. Moreover, it has been suggested that this effect 
could be more pronounced for larger deletion variants interrupting genes of vital 
importance; consequently this effect is more likely under stronger (prenatal) 
selection. The opposite effect that was observed for a slightly increased 
transmission rate for longer (>100 kb) duplications (although this did not reach 
statistical significance) could possibly be explained by the contribution of 
duplications in providing the means for functional redundancy and facilitating 
exon shuffling, gene fusion and gene duplication. By generating new functional 
genes, duplication events may be an important mechanism for long-term 
evolutionary changes in humans and thus occur under positive selection. 
Although similar results were also observed in several earlier studies, only a 
very cautious interpretation of both findings should be considered. Larger 
studies with high-resolution platforms and validation techniques are merited to 
confirm and further investigate these interesting phenomena.  
 
4.2 Putative de novo copy number variants (Ref. IV) 
The process of directly deleterious variants being under negative selection and 
thus systematically under-transmitted from generation to generation is balanced 
by germline mutation events that generate de novo variants that are observable 
in new generations. 
In our combined dataset we detected 27 CNVs that were identified as 
putative de novo copy number alterations in the offspring. Out of these 27 
putative de novo CNVs, 20 were deletions and 7 were duplication events. As 
determined by our algorithm and confirmed by manual inspection, five out of 
nine unambiguously phased putative de novo CNVs appeared on maternally 
inherited chromosomes and four on a paternally inherited chromosome. We use 
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the term ‘putative’ de novo CNVs because such variants might not be true de 
novo mutations even if these CNVs are unambiguously phased and validated by 
other experimental methods. Alternatively, these can be somatically derived 
cloned mutations or artefacts often observed when DNA from cell-lines is 
analysed. De novo CNVs might also appear due to complex haplotype 
compositions of a studied family in a given locus (e.g., in CNP loci where 
haplotypes with 0 and 2 copies are combined in one parent, leading to incorrect 
calling of de novo variants from unphased CNV data, thereby highlighting the 
relevance of phasing of the exact parental haplotypes).  
 
4.2 Allelic variability in duplication CNV regions (Ref. IV) 
Deterministic phasing within CNV regions allowed us to differentiate between 
normal and CNV-carrying haplotypes with different allelic compositions and to 
more extensively study the allelic variability within the discovered copy number 
gain-carrying haplotypes. Because alternative allelic copies within CNV regions 
may modify the severity of a phenotype (including disease susceptibility), we 
aimed to determine the occurrence of alternative allelic copies within these 
multi-copy haplotypes.  
We studied these CNV regions in a combined dataset where one or both 
parents of the same family had duplication or triplication-carrying haplotypes in 
the same regions. We determined that informative polymorphic genotypes were 
present within the multi-copy haplotypes in 93% of such CNV regions. 
Therefore, it was possible to phase and differentiate between normal and multi-
copy haplotypes (as shown in Figure 3). Furthermore, heterozygous genotypes 
were also present within the multi-copy haplotypes in 67% of these CNV 
regions (Figure 7), thereby allowing us to define alternative allelic copies within 
these copy number gain-carrying haplotypes and demonstrating extensive and 
to-date unmeasured allelic variability in multi-copy CNV regions in the human 
genome.  
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Figure 7. Allelic variability in CNV regions and within duplication CNVs. SNP-
based genotypes within duplicated region that are polymorphic between normal 
(haploid copy number cn=1) and duplication-carrying haplotypes (cn=2) are indicated 
with dashed rectangles. The duplication-carrying haplotype is composed of two allelic 
copies distinguished by single nucleotide variants (indicated as SNP7 and SNP15) that 
are polymorphic within the duplication-carrying haplotype (depicted by a dotted 
rectangle). 
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SUMMARY AND CONCLUSIONS 
Using statistical and computational methods, we studied copy number variants 
(CNVs) and different CNV-related aspects of the human genome. The most 
important results of this thesis are as follows: 
 
1. We developed computational methods and software for phasing haplotypes 
within CNV regions in nuclear families based on SNP genotyping microarray 
data. Using two different datasets, we determined that it was possible to 
unambiguously phase all parental haplotypes and follow their transmission in 
offspring in the vast majority of CNV regions. 
 
2. By counting the number of transmission events of normal or CNV-carrying 
haplotypes in two family datasets, we found that CNV-carrying haplotypes were 
observed in offspring less frequently than expected by Mendelian inheritance. 
This results suggests the systematic under-transmission of CNVs. This trend 
was stronger for deletion-carrying haplotypes. 
 
3. We determined that the copies represented different alleles in two-thirds of 
the studied duplication-carrying CNV regions. This result demonstrates the 
extensive allelic variability in multi-copy CNV regions of the human genome. 
 
 
  
32 
REFERENCES 
1. Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait 
associations. Nucleic Acids Res 42, D1001–6 (2014). 
2. MacArthur, D.G. et al. A systematic survey of loss-of-function variants in human 
protein-coding genes. Science 335, 823–8 (2012). 
3. Ophir, R. & Graur, D. Patterns and rates of indel evolution in processed 
pseudogenes from humans and murids. Gene 205, 191–202 (1997). 
4. Kondrashov, A.S. & Rogozin, I.B. Context of deletions and insertions in human 
coding sequences. Hum Mutat 23, 177–85 (2004). 
5. Iafrate, A.J. et al. Detection of large-scale variation in the human genome. Nat 
Genet 36, 949–51 (2004). 
6. Sebat, J. et al. Large-scale copy number polymorphism in the human genome. 
Science 305, 525–8 (2004). 
7. Redon, R. et al. Global variation in copy number in the human genome. Nature 
444, 444–54 (2006). 
8. Feuk, L., Carson, A.R. & Scherer, S.W. Structural variation in the human genome. 
Nat Rev Genet 7, 85–97 (2006). 
9. Conrad, D.F. et al. Origins and functional impact of copy number variation in the 
human genome. Nature 464, 704–12 (2010). 
10. McCarroll, S.A. et al. Integrated detection and population-genetic analysis of 
SNPs and copy number variation. Nat Genet 40, 1166–74 (2008). 
11. Mills, R.E. et al. Mapping copy number variation by population-scale genome 
sequencing. Nature 470, 59–65 (2011). 
12. MacDonald, J.R., Ziman, R., Yuen, R.K., Feuk, L. & Scherer, S.W. The Database 
of Genomic Variants: a curated collection of structural variation in the human 
genome. Nucleic Acids Res 42, D986–92 (2014). 
13. Zarrei, M., MacDonald, J.R., Merico, D. & Scherer, S.W. A copy number variation 
map of the human genome. Nat Rev Genet 16, 172–83 (2015). 
14. Tuzun, E. et al. Fine-scale structural variation of the human genome. Nat Genet 
37, 727–32 (2005). 
15. Korbel, J.O. et al. Paired-end mapping reveals extensive structural variation in the 
human genome. Science 318, 420–6 (2007). 
16. Itsara, A. et al. Population analysis of large copy number variants and hotspots of 
human genetic disease. Am J Hum Genet 84, 148–61 (2009). 
17. Pinto, D., Marshall, C., Feuk, L. & Scherer, S.W. Copy-number variation in 
control population cohorts. Hum Mol Genet 16 Spec No. 2, R168–73 (2007). 
18. Cooper, G.M., Nickerson, D.A. & Eichler, E.E. Mutational and selective effects on 
copy-number variants in the human genome. Nat Genet 39, S22–9 (2007). 
19. Zhang, F., Gu, W., Hurles, M.E. & Lupski, J.R. Copy number variation in human 
health, disease, and evolution. Annu Rev Genomics Hum Genet 10, 451–81 (2009). 
20. Kato, M. et al. Population-genetic nature of copy number variations in the human 
genome. Hum Mol Genet 19, 761–73 (2010). 
21. Ankala, A. et al. Aberrant firing of replication origins potentially explains 
intragenic nonrecurrent rearrangements within genes, including the human DMD 
gene. Genome Res 22, 25–34 (2012). 
33 
22. Chen, J.M., Cooper, D.N., Ferec, C., Kehrer-Sawatzki, H. & Patrinos, G.P. Ge-
nomic rearrangements in inherited disease and cancer. Semin Cancer Biol 20, 222–
33 (2010). 
23. Chen, J.-M. Genomic Rearrangements: Mutational Mechanisms. (2011). 
24. Turner, D.J. et al. Germline rates of de novo meiotic deletions and duplications 
causing several genomic disorders. Nat Genet 40, 90–5 (2008). 
25. Liu, P., Carvalho, C.M., Hastings, P.J. & Lupski, J.R. Mechanisms for recurrent 
and complex human genomic rearrangements. Curr Opin Genet Dev 22, 211–20 
(2012). 
26. Lieber, M.R. The mechanism of human nonhomologous DNA end joining. J Biol 
Chem 283, 1–5 (2008). 
27. Lee, J.A., Carvalho, C.M. & Lupski, J.R. A DNA replication mechanism for 
generating nonrecurrent rearrangements associated with genomic disorders. Cell 
131, 1235–47 (2007). 
28. Hastings, P.J., Ira, G. & Lupski, J.R. A microhomology-mediated break-induced 
replication model for the origin of human copy number variation. PLoS Genet 5, 
e1000327 (2009). 
29. Zhang, F. et al. The DNA replication FoSTeS/MMBIR mechanism can generate 
genomic, genic and exonic complex rearrangements in humans. Nat Genet 41, 
849–53 (2009). 
30. Chen, J.M., Chuzhanova, N., Stenson, P.D., Ferec, C. & Cooper, D.N. Complex 
gene rearrangements caused by serial replication slippage. Hum Mutat 26, 125–34 
(2005). 
31. de Ligt, J. et al. Detection of clinically relevant copy number variants with whole-
exome sequencing. Hum Mutat 34, 1439–48 (2013). 
32. de Ligt, J. et al. Platform comparison of detecting copy number variants with 
microarrays and whole-exome sequencing. Genomics Data 2, 144–146 (2014). 
33. Bignell, G.R. et al. High-resolution analysis of DNA copy number using 
oligonucleotide microarrays. Genome Res 14, 287–95 (2004). 
34. Peiffer, D.A. et al. High-resolution genomic profiling of chromosomal aberrations 
using Infinium whole-genome genotyping. Genome Res 16, 1136–48 (2006). 
35. Kloth, J.N. et al. Combined array-comparative genomic hybridization and single-
nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic 
alterations in cervical cancer. BMC Genomics 8, 53 (2007). 
36. Lockwood, W.W., Chari, R., Chi, B. & Lam, W.L. Recent advances in array 
comparative genomic hybridization technologies and their applications in human 
genetics. Eur J Hum Genet 14, 139–48 (2006). 
37. Price, T.S. et al. SW-ARRAY: a dynamic programming solution for the identi-
fication of copy-number changes in genomic DNA using array comparative 
genome hybridization data. Nucleic Acids Res 33, 3455–64 (2005). 
38. Yu, W. et al. Development of a comparative genomic hybridization microarray 
and demonstration of its utility with 25 well-characterized 1p36 deletions. Hum 
Mol Genet 12, 2145–52 (2003). 
39. Campbell, C.D. et al. Population-genetic properties of differentiated human copy-
number polymorphisms. Am J Hum Genet 88, 317–32 (2011). 
40. Wang, K. & Bucan, M. Copy Number Variation Detection via High-Density SNP 
Genotyping. CSH Protoc 2008, pdb top46 (2008). 
41. Li, W. & Olivier, M. Current analysis platforms and methods for detecting copy 
number variation. Physiol Genomics 45, 1–16 (2013). 
9
34 
42. Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-
resolution copy number variation detection in whole-genome SNP genotyping 
data. Genome Res 17, 1665–74 (2007). 
43. Menten, B. et al. arrayCGHbase: an analysis platform for comparative genomic 
hybridization microarrays. BMC Bioinformatics 6, 124 (2005). 
44. Lingjaerde, O.C., Baumbusch, L.O., Liestol, K., Glad, I.K. & Borresen-Dale, A.L. 
CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics 21, 
821–2 (2005). 
45. Veltman, J.A. et al. High-throughput analysis of subtelomeric chromosome re-
arrangements by use of array-based comparative genomic hybridization. Am J 
Hum Genet 70, 1269–76 (2002). 
46. Kim, S.Y. et al. ArrayCyGHt: a web application for analysis and visualization of 
array-CGH data. Bioinformatics 21, 2554–5 (2005). 
47. Diskin, S.J. et al. STAC: A method for testing the significance of DNA copy 
number aberrations across multiple array-CGH experiments. Genome Res 16, 
1149–58 (2006). 
48. Wang, J., Meza-Zepeda, L.A., Kresse, S.H. & Myklebost, O. M-CGH: analysing 
microarray-based CGH experiments. BMC Bioinformatics 5, 74 (2004). 
49. Picard, F., Robin, S., Lavielle, M., Vaisse, C. & Daudin, J.J. A statistical approach 
for array CGH data analysis. BMC Bioinformatics 6, 27 (2005). 
50. Myers, C.L., Chen, X. & Troyanskaya, O.G. Visualization-based discovery and 
analysis of genomic aberrations in microarray data. BMC Bioinformatics 6, 146 
(2005). 
51. Yang, H. & Churchill, G. Estimating p-values in small microarray experiments. 
Bioinformatics 23, 38–43 (2007). 
52. Colella, S. et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect 
and accurately map copy number variation using SNP genotyping data. Nucleic 
Acids Res 35, 2013–25 (2007). 
53. Winchester, L., Yau, C. & Ragoussis, J. Comparing CNV detection methods for 
SNP arrays. Brief Funct Genomic Proteomic 8, 353–66 (2009). 
54. Pinto, D. et al. Comprehensive assessment of array-based platforms and calling 
algorithms for detection of copy number variants. Nat Biotechnol 29, 512–20 
(2011). 
55. Kim, S.Y., Kim, J.H. & Chung, Y.J. Effect of Combining Multiple CNV Defining 
Algorithms on the Reliability of CNV Calls from SNP Genotyping Data. 
Genomics Inform 10, 194–9 (2012). 
56. McCarroll, S.A. & Altshuler, D.M. Copy-number variation and association studies 
of human disease. Nat Genet 39, S37–42 (2007). 
57. Stranger, B.E. et al. Relative impact of nucleotide and copy number variation on 
gene expression phenotypes. Science 315, 848–53 (2007). 
58. Henrichsen, C.N. et al. Segmental copy number variation shapes tissue 
transcriptomes. Nat Genet 41, 424–9 (2009). 
59. Kurotaki, N., Stankiewicz, P., Wakui, K., Niikawa, N. & Lupski, J.R. Sotos 
syndrome common deletion is mediated by directly oriented subunits within 
inverted Sos-REP low-copy repeats. Hum Mol Genet 14, 535–42 (2005). 
60. Lupski, J.R. et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease 
type 1A. Nat Genet 1, 29–33 (1992). 
35 
61. Brahmachary, M. et al. Digital genotyping of macrosatellites and multicopy genes 
reveals novel biological functions associated with copy number variation of large 
tandem repeats. PLoS Genet 10, e1004418 (2014). 
62. Girirajan, S., Campbell, C.D. & Eichler, E.E. Human copy number variation and 
complex genetic disease. Annu Rev Genet 45, 203–26 (2011). 
63. Perry, G.H. et al. Diet and the evolution of human amylase gene copy number 
variation. Nat Genet 39, 1256–60 (2007). 
64. Nathans, J., Thomas, D. & Hogness, D.S. Molecular genetics of human color 
vision: the genes encoding blue, green, and red pigments. Science 232, 193–202 
(1986). 
65. Deeb, S.S. The molecular basis of variation in human color vision. Clin Genet 67, 
369–77 (2005). 
66. Deeb, S.S. Genetics of variation in human color vision and the retinal cone mosaic. 
Curr Opin Genet Dev 16, 301–7 (2006). 
67. Jakobsson, J. et al. Large differences in testosterone excretion in Korean and 
Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 
polymorphism. J Clin Endocrinol Metab 91, 687–93 (2006). 
68. Wagner, F.F. & Flegel, W.A. Review: the molecular basis of the Rh blood group 
phenotypes. Immunohematology 20, 23–36 (2004). 
69. Singleton, A.B. et al. alpha-Synuclein locus triplication causes Parkinson's disease. 
Science 302, 841 (2003). 
70. Estivill, X. & Armengol, L. Copy number variants and common disorders: filling 
the gaps and exploring complexity in genome-wide association studies. PLoS 
Genet 3, 1787–99 (2007). 
71. Lee, C. & Scherer, S.W. The clinical context of copy number variation in the 
human genome. Expert Rev Mol Med 12, e8 (2010). 
72. Stankiewicz, P. & Lupski, J.R. Structural variation in the human genome and its 
role in disease. Annu Rev Med 61, 437–55 (2010). 
73. Aitman, T.J. et al. Copy number polymorphism in Fcgr3 predisposes to 
glomerulonephritis in rats and humans. Nature 439, 851–5 (2006). 
74. Fellermann, K. et al. A chromosome 8 gene-cluster polymorphism with low 
human beta-defensin 2 gene copy number predisposes to Crohn disease of the 
colon. Am J Hum Genet 79, 439–48 (2006). 
75. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. 
Nature (2014). 
76. Gonzalez, E. et al. The influence of CCL3L1 gene-containing segmental 
duplications on HIV-1/AIDS susceptibility. Science 307, 1434–40 (2005). 
77. Nakajima, T., Kaur, G., Mehra, N. & Kimura, A. HIV-1/AIDS susceptibility and 
copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-
receptor CCR5. Cytogenet Genome Res 123, 156–60 (2008). 
78. Lakich, D., Kazazian, H.H., Jr., Antonarakis, S.E. & Gitschier, J. Inversions 
disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat 
Genet 5, 236–41 (1993). 
79. Chartier-Harlin, M.C. et al. Alpha-synuclein locus duplication as a cause of 
familial Parkinson's disease. Lancet 364, 1167–9 (2004). 
80. Ibanez, P. et al. Causal relation between alpha-synuclein gene duplication and 
familial Parkinson's disease. Lancet 364, 1169–71 (2004). 
81. Cabrejo, L. et al. Phenotype associated with APP duplication in five families. 
Brain 129, 2966–76 (2006). 
36 
82. Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-
onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38, 24–6 
(2006). 
83. Theuns, J. et al. Promoter mutations that increase amyloid precursor-protein 
expression are associated with Alzheimer disease. Am J Hum Genet 78, 936–46 
(2006). 
84. Walters, R.G. et al. A new highly penetrant form of obesity due to deletions on 
chromosome 16p11.2. Nature 463, 671–5 (2010). 
85. Willer, C.J. et al. Six new loci associated with body mass index highlight a 
neuronal influence on body weight regulation. Nat Genet 41, 25–34 (2009). 
86. Wheeler, E. et al. Genome-wide SNP and CNV analysis identifies common and 
low-frequency variants associated with severe early-onset obesity. Nat Genet 45, 
513–7 (2013). 
87. Cook, E.H., Jr. & Scherer, S.W. Copy-number variations associated with neuro-
psychiatric conditions. Nature 455, 919–23 (2008). 
88. Kirov, G. et al. Support for the involvement of large copy number variants in the 
pathogenesis of schizophrenia. Hum Mol Genet 18, 1497–503 (2009). 
89. Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. 
Nature 455, 232–6 (2008). 
90. Stefansson, H. et al. Common variants conferring risk of schizophrenia. Nature 
460, 744–7 (2009). 
91. Autism Genome Project, C. et al. Mapping autism risk loci using genetic linkage 
and chromosomal rearrangements. Nat Genet 39, 319–28 (2007). 
92. Glessner, J.T. et al. Autism genome-wide copy number variation reveals ubiquitin 
and neuronal genes. Nature 459, 569–73 (2009). 
93. Marshall, C.R. et al. Structural variation of chromosomes in autism spectrum 
disorder. Am J Hum Genet 82, 477–88 (2008). 
94. Szatmari, P. et al. Mapping autism risk loci using genetic linkage and chromo-
somal rearrangements. Nat Genet 39, 319–28 (2007). 
95. Weiss, L.A. et al. Association between microdeletion and microduplication at 
16p11.2 and autism. N Engl J Med 358, 667–75 (2008). 
96. Yang, Y. et al. Gene copy-number variation and associated polymorphisms of 
complement component C4 in human systemic lupus erythematosus (SLE): low 
copy number is a risk factor for and high copy number is a protective factor 
against SLE susceptibility in European Americans. Am J Hum Genet 80, 1037–54 
(2007). 
97. de Cid, R. et al. Deletion of the late cornified envelope LCE3B and LCE3C genes 
as a susceptibility factor for psoriasis. Nat Genet 41, 211–5 (2009). 
98. Hollox, E.J. et al. Psoriasis is associated with increased beta-defensin genomic 
copy number. Nat Genet 40, 23–5 (2008). 
99. Fanciulli, M. et al. FCGR3B copy number variation is associated with 
susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39, 
721–3 (2007). 
100. Willcocks, L.C. et al. Copy number of FCGR3B, which is associated with 
systemic lupus erythematosus, correlates with protein expression and immune 
complex uptake. J Exp Med 205, 1573–82 (2008). 
101. Potocki, L. et al. DNA rearrangements on both homologues of chromosome 17 in 
a mildly delayed individual with a family history of autosomal dominant carpal 
tunnel syndrome. Am J Hum Genet 64, 471–8 (1999). 
37 
102. Rees, E., Moskvina, V., Owen, M.J., O'Donovan, M.C. & Kirov, G. De novo rates 
and selection of schizophrenia-associated copy number variants. Biol Psychiatry 
70, 1109–14 (2011). 
103. International Schizophrenia, C. Rare chromosomal deletions and duplications 
increase risk of schizophrenia. Nature 455, 237–41 (2008). 
104. Cooper, G.M. et al. A copy number variation morbidity map of developmental 
delay. Nat Genet 43, 838–46 (2011). 
105. Pinto, D. et al. Convergence of genes and cellular pathways dysregulated in autism 
spectrum disorders. Am J Hum Genet 94, 677–94 (2014). 
106. Schaaf, C.P., Wiszniewska, J. & Beaudet, A.L. Copy number and SNP arrays in 
clinical diagnostics. Annu Rev Genomics Hum Genet 12, 25–51 (2011). 
107. Mefford, H.C. et al. Recurrent rearrangements of chromosome 1q21.1 and variable 
pediatric phenotypes. N Engl J Med 359, 1685–99 (2008). 
108. Wellcome Trust Case Control, C. et al. Genome-wide association study of CNVs 
in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464, 
713–20 (2010). 
109. Kirov, G. et al. The penetrance of copy number variations for schizophrenia and 
developmental delay. Biol Psychiatry 75, 378–85 (2014). 
110. Stefansson, H. et al. CNVs conferring risk of autism or schizophrenia affect 
cognition in controls. Nature 505, 361–6 (2014). 
111. Cooper, D.N., Krawczak, M., Polychronakos, C., Tyler-Smith, C. & Kehrer-
Sawatzki, H. Where genotype is not predictive of phenotype: towards an 
understanding of the molecular basis of reduced penetrance in human inherited 
disease. Hum Genet 132, 1077–130 (2013). 
112. Conrad, D.F., Andrews, T.D., Carter, N.P., Hurles, M.E. & Pritchard, J.K. A high-
resolution survey of deletion polymorphism in the human genome. Nat Genet 38, 
75–81 (2006). 
113. Derti, A., Roth, F.P., Church, G.M. & Wu, C.T. Mammalian ultraconserved 
elements are strongly depleted among segmental duplications and copy number 
variants. Nat Genet 38, 1216–20 (2006). 
114. Bejerano, G. et al. Ultraconserved elements in the human genome. Science 304, 
1321–5 (2004). 
115. Ionita-Laza, I. et al. On the analysis of copy-number variations in genome-wide 
association studies: a translation of the family-based association test. Genet 
Epidemiol 32, 273–84 (2008). 
116. Handsaker, R.E. et al. Large multiallelic copy number variations in humans. Nat 
Genet 47, 296–303 (2015). 
117. Barnes, C. et al. A robust statistical method for case-control association testing 
with copy number variation. Nat Genet 40, 1245–52 (2008). 
118. Eleftherohorinou, H. et al. famCNV: copy number variant association for 
quantitative traits in families. Bioinformatics 27, 1873–5 (2011). 
119. Wang, K. et al. Modeling genetic inheritance of copy number variations. Nucleic 
Acids Res 36, e138 (2008). 
120. Korn, J.M. et al. Integrated genotype calling and association analysis of SNPs, 
common copy number polymorphisms and rare CNVs. Nat Genet 40, 1253–60 
(2008). 
121. Macconaill, L.E., Aldred, M.A., Lu, X. & Laframboise, T. Toward accurate high-
throughput SNP genotyping in the presence of inherited copy number variation. 
BMC Genomics 8, 211 (2007). 
10
38 
122. Katagiri, T. et al. Frequent loss of HLA alleles associated with copy number-
neutral 6pLOH in acquired aplastic anemia. Blood 118, 6601–9 (2011). 
123. Clark, A., Dermitzakis, E. & Antonarakis, S. Trisomic Phase Inference. in 
Computational Methods for SNPs and Haplotype Inference, Vol. 2983 (eds. Istrail, 
S., Waterman, M. & Clark, A.) 1–8 (Springer Berlin Heidelberg, 2004). 
124. Manolio, T.A. et al. Finding the missing heritability of complex diseases. Nature 
461, 747–53 (2009). 
125. Bansal, V., Tewhey, R., Topol, E.J. & Schork, N.J. The next phase in human 
genetics. Nat Biotechnol 29, 38–9 (2011). 
126. Gudbjartsson, D.F. et al. Large-scale whole-genome sequencing of the Icelandic 
population. Nat Genet 47, 435–44 (2015). 
127. Alkan, C., Coe, B.P. & Eichler, E.E. Genome structural variation discovery and 
genotyping. Nat Rev Genet 12, 363–76 (2011). 
128. Gamazon, E.R., Cox, N.J. & Davis, L.K. Structural Architecture of SNP Effects on 
Complex Traits. Am J Hum Genet (2014). 
129. Wang, W., Wang, W., Sun, W., Crowley, J.J. & Szatkiewicz, J.P. Allele-specific 
copy-number discovery from whole-genome and whole-exome sequencing. 
Nucleic Acids Res (2015). 
130. Perry, G.H. et al. The fine-scale and complex architecture of human copy-number 
variation. Am J Hum Genet 82, 685–95 (2008). 
131. Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 
409, 860–921 (2001). 
132. Pollack, J.R. et al. Microarray analysis reveals a major direct role of DNA copy 
number alteration in the transcriptional program of human breast tumors. Proc 
Natl Acad Sci U S A 99, 12963–8 (2002). 
133. Albertson, D.G. & Pinkel, D. Genomic microarrays in human genetic disease and 
cancer. Hum Mol Genet 12 Spec No 2, R145–52 (2003). 
 
 
  
39 
SUMMARY IN ESTONIAN 
Arvutuslikud meetodid DNA koopiaarvu määramiseks 
Arusaamine, et inimesed on oma geneetiliste materjali poolest erinevad, on 
suhteliselt vana. Ometigi sai võimalikuks ja algas selliste erinevuste ulatuslik ja 
süstemaatiline uurimine inimese genoomis alles suhteliselt hiljuti, uue aasta-
tuhande alguses. Pärast inimese genoomi täieliku primaarjärjestuse esimese 
versiooni avaldamist131 algas ulatuslik indiviidide ja erinevate populatsioonide 
vaheliste geneetiliste erinevuste (variantide) otsimine ja kaardistamine. See 
andis uut hoogu ka inimese haigusseoseliste geneetiliste variantide otsimisele ja 
kirjeldamisele. Paljude aastate jooksul keskenduti enamasti ühenukleotiidsete 
variantide ehk SNP-de otsimisele, sest olemasolevad tehnoloogilised vahendid 
ja metoodikad võimaldasid neid kõige lihtsamini suures mahus leida ja kirjeldada.  
Kuigi juba aastakümneid oli tegelikult olnud teada, et erinevatel inimestel 
võivad olla erinevused ka pikemates DNA primaarjärjestuse lõikudes, sai DNA 
pikemate erinevuste, sealhulgas ka DNA koopiaarvu muutuste (ingl. copy 
number variant ehk CNV) süstemaatiline ja ulatuslik uurimine hoo sisse alles 
2003. aastal. Ja kui esialgu uuriti ja seostati selliseid suuremaid muutusi DNA 
primaarjärjestuses tihtipeale erinevate tõsiste geneetiliste haigustega ja kasva-
jatega132,133, sai peagi ühemõtteliselt selgeks, et sellised pikemad DNA ümber-
korralduste variandid ei esine ainult seoses tõsiste haigustega, vaid on suhte-
liselt sagedased ka tervete inimeste geneetilises materjalis ja moodustavad suure 
osa indiviidide vahelistest erinevustest DNA tasemel5–7.  
Sellised muutused võivad olla väga erineva suurusega, alates tervete kromo-
soomide kordistumisest/kaotsiminekust kuni geenide ja üksikute eksonite dup-
litseerumiseni (koopiate kordistumine) või deleteerumiseni (koopiate kaotsi-
minek). Et eristada haigustpõhjustavaid CNV-sid normaalsetest ”tervete” 
inimeste vahelisest koopiaarvu variantidest, on tähtis aru saada sellest, kui suur 
on inimeste vaheline normaalne varieeruvus DNA koopiaarvu variantide tase-
mel. Seetõttu on oluline töötada välja uusi ja arendada edasi olemasolevaid 
ekperimentaalseid ja arvutuslikke meetodeid, millega detekteerida ja uurida 
DNA koopiaarvu muutusi inimese genoomis. 
Käesoleva doktoritöö kirjanduse ülevaade keskendub DNA koopiaarvu 
variantide ja tekkemehhanismide kirjeldamisele. Samuti antakse ülevaade 
koopiaarvu variantidega senini seostatud fenotüüpidest, sealhulgas haigustest. 
Kirjeldatakse DNA koopiaarvu leidmiseks kasutatavate mikrokiipide tööpõhi-
mõtteid ja olemasolevad arvutuslikke vahendeid. 
Antud doktoritöö raames töötati välja erinevaid arvutuslikke meetodeid ja 
lahendusi DNA koopiaarvu muutuste leidmiseks ja nendega töötamiseks. 
Kõigepealt töötati välja statistiline raamistik ja arvutuslik metoodika CNV-de 
detekteerimiseks X-kromosoomi spetsiifiliselt mikrokiibilt. Kui hakkasime 
kasutama algselt SNP-de genotüpiseerimiseks mõeldud kogu genoomi katvaid 
mikrokiipe, tekkis vajadus leida ja automatiseerida meie andmetele ja kiipidele 
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sobivad CNV-de detekteerimise ja filtreerimise arvutuslikud lahendused tark-
vara töövoogudena. 
Uurides CNV-sid perekondade andmetest oli vaja täpselt määrata, milline 
(oletatavalt haigus-seoseline) koopiaarvu muutus milliselt vanemalt on lapsele/ 
lastele pärandunud. Selle tarvis sai välja töötatud uudne arvutuslik metoodika, 
mis kasutades SNP mikrokiibi andmeid võimaldab faasida ja „järgida“ CNV-sid 
kandvate haplotüüpide pärandumist vanematelt lastele. 
Käesoleva töö viimases osas uurisime me lisaks haigusseoseliste variantidele 
ka Tartu Ülikooli Eesti Geenivaramu ja rahvusvahelise HapMap projekti poolt 
kogutud tervetel inimestel esinevaid DNA koopiaarvu muutusi ja nende päran-
dumist perekondades. Selle uuringu üheks huvitavamaks tulemuseks oli delet-
sioonide „alapärandumine“ vanematelt lastele, st. deletsioone kandvaid haplo-
tüüpe esines laste genoomides oluliselt vähem, kui Mendeliaalse pärandumise 
korral oodata oleks võinud. Teiseks huvitavaks tulemuseks oli de novo ehk uute 
DNA koopiaarvu muutuste leidmine – nimelt esines paljude laste genoomides 
selliseid DNA koopiaarvu variante, mida kummagi vanema genoomis ei olnud. 
Kolmandaks, uurides duplikatsioone perekondades faasitud CNV-de regiooni-
des, leidsime me, et kaks kolmandikku (67%) duplikatsioonides esinevatest 
alleelsetest koopiatest ei olnud identsed, vaid mõnevõrra erinevad, demonst-
reerides seni teadmata olnud alleelse varieeruvuse määra DNA koopiaarvu 
korduste regioonides. 
 
 
 
  
41 
ACKNOWLEDGEMENTS 
Dear Lord, do not give me light; 
Let it be yours and yours alone; 
But grant me a sincere desire 
To strive towards it. 
 
Desiderius Erasmus 
 
First, I thank my supervisor Prof. Maido Remm, who throughout my years in 
bioinformatics has guided me with insightful thoughts and proper criticism. 
From Maido I learned my affection for a systematic way of thinking and 
working and the pursuit of accuracy. Thank you! 
I am grateful to all my wonderful colleagues at University of Tartu. Thank 
you for your help and advice and for of all these interesting discussions and 
good times! My special thanks go to Lauris Kaplinski, Reidar Andreson, Reedik 
Mägi, Priit ‘Lemps’ Adler and Hedi Peterson. 
I thank all of the co-authors of the papers on which this thesis is based. In 
my glimpse into statistics (which has proven to be extremely useful), Tõnu and 
Märt Möls have been my guides. Thank you all! 
I am grateful to Prof. Aarno Palotie for always pushing me forward. I truly 
admire your energy, politeness and way of doing science! 
Last but not least, I want to thank my friends and my family. Nevil, Jurgen, 
Lauri, Marek, Heikko, Kaarel and all others – you are the best! My dear Mirell, 
Mihkel and Marie – thank you for tolerating my unusual work with all of these 
travels and late night or weekend working hours. Thank you for giving meaning 
to my life and a desire to move onward and upward! 
 
  
11
  
 
 
 
PUBLICATIONS 
 
  
CURRICULUM VITAE 
Name: Priit Palta 
Date of birth: April 25, 1981 
Address: Institute of Molecular and Cell Biology, 23 Riia St., 51010 
Tartu  
E-mail: priit.palta@ut.ee 
Current position: Research scientist, Institute for Molecular Medicine Finland 
(FIMM), University of Helsinki 
 
Education: 
2007–2011 Ph.D. student in bioinformatics, Institute of Molecular and 
Cell Biology, University of Tartu 
2005–2007 M.Sc. student in bioinformatics, Institute of Molecular and 
Cell Biology, University of Tartu 
2000–2005 B.Sc. student in bioinformatics, Institute of Molecular and 
Cell Biology, University of Tartu 
1994–2000 Tartu Mart Reinik’s Gymnasium 
1988–1994 12th High School of Tartu 
 
Working experience: 
Since 2013 Research scientist, Institute for Molecular Medicine Finland 
(FIMM), University of Helsinki 
2011–2013 Visiting scientist, Wellcome Trust Sanger Institute 
2007–2011 Research scientist, Estonian Biocentre 
2005–2007 Bioinformatics specialist, Estonian Biocentre 
2004–2008 Bioinformatics specialist, Institute of Molecular and Cell 
Biology, University of Tartu 
 
Main fields of research: 
DNA copy number variants in health and disease; rare genetic variants in 
migraine and schizophrenia; enriched (loss-of-function) variants in isolated 
populations. 
 
Publications: 
Palta P, Kaplinski L, Nagirnaja L, Veidenberg A, Möls M, Esko T, Nelis M, 
Metspalu A, Laan M, Remm M. Haplotype phasing and inheritance of 
copy number variants in nuclear families. PLoS One. 2015;10(4):e0122713. 
doi: 10.1371/journal.pone.0122713. PubMed PMID:25853576. 
Nagirnaja L, Palta P, Kasak L, Rull K, Christiansen OB, Nielsen HS, Steffensen 
R, Esko T, Remm M, Laan M. Structural genomic variation as risk factor 
for idiopathic recurrent miscarriage. Hum Mutat. 2014 Aug;35(8):972–
82. doi: 10.1002/humu.22589. Epub 2014 Jun 24. PubMed PMID: 24827138. 
106
 Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, Esko T, 
Mägi R, Inouye M, Lappalainen T, Chan Y, Salem RM, Lek M, Flannick J, 
Sim X, Manning A, Ladenvall C, Bumpstead S, Hämäläinen E, Aalto K, 
Maksimow M, Salmi M, Blankenberg S, Ardissino D, Shah S, Horne B, 
McPherson R, Hovingh GK, Reilly MP, Watkins H, Goel A, Farrall M, 
Girelli D, Reiner AP, Stitziel NO, Kathiresan S, Gabriel S, Barrett JC, 
Lehtimäki T, Laakso M, Groop L, Kaprio J, Perola M, McCarthy MI, 
Boehnke M, Altshuler DM, Lindgren CM, Hirschhorn JN, Metspalu A, 
Freimer NB, Zeller T, Jalkanen S, Koskinen S, Raitakari O, Durbin R, 
MacArthur DG, Salomaa V, Ripatti S, Daly MJ, Palotie A; Sequencing 
Initiative Suomi (SISu) Project. Distribution and Medical Impact of Loss-
of-Function Variants in the Finnish Founder Population. PLoS Genet. 
2014 Jul 31;10(7):e1004494. doi: 10.1371/journal.pgen.1004494. eCollection 
2014 Jul. PubMed PMID: 25078778. 
Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, 
Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson 
JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose 
SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, 
McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, O'Donovan MC. 
De novo mutations in schizophrenia implicate synaptic networks. 
Nature. 2014 Feb 13;506(7487):179–84. doi: 10.1038/nature12929. Epub 
2014 Jan 22. PubMed PMID: 24463507. 
Zilbauer M, Rayner TF, Clark C, Coffey AJ, Joyce CJ, Palta P, Palotie A, Lyons 
PA, Smith KG. Genome-wide methylation analyses of primary human 
leukocyte subsets identifies functionally important cell-type-specific hypo-
methylated regions. Blood. 2013 Dec 12;122(25):e52-60. doi: 10.1182/ 
blood-2013-05-503201. Epub 2013 Oct 24. PubMed PMID: 24159175. 
Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, Kallela 
M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U, McArdle WL, 
Quaye L, Koiranen M, Ikram MA, Lehtimäki T, Stam AH, Ligthart L, 
Wedenoja J, Dunham I, Neale BM, Palta P, Hamalainen E, Schürks M, Rose 
LM, Buring JE, Ridker PM, Steinberg S, Stefansson H, Jakobsson F, Lawlor 
DA, Evans DM, Ring SM, Färkkilä M, Artto V, Kaunisto MA, Freilinger T, 
Schoenen J, Frants RR, Pelzer N, Weller CM, Zielman R, Heath AC, 
Madden PA, Montgomery GW, Martin NG, Borck G, Göbel H, Heinze A, 
Heinze-Kuhn K, Williams FM, Hartikainen AL, Pouta A, van den Ende J, 
Uitterlinden AG, Hofman A, Amin N, Hottenga JJ, Vink JM, Heikkilä K, 
Alexander M, Muller-Myhsok B, Schreiber S, Meitinger T, Wichmann HE, 
Aromaa A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E, Lage K, Jacobs 
SB, Gibbs JR, Birney E, Kaprio J, Penninx BW, Boomsma DI, van Duijn C, 
Raitakari O, Jarvelin MR, Zwart JA, Cherkas L, Strachan DP, Kubisch C, 
Ferrari MD, van den Maagdenberg AM, Dichgans M, Wessman M, Smith 
GD, Stefansson K, Daly MJ, Nyholt DR, Chasman DI, Palotie A; North 
American Brain Expression Consortium; UK Brain Expression Consortium; 
107
 International Headache Genetics Consortium. Genome-wide meta-analysis 
identifies new susceptibility loci for migraine. Nat Genet. 2013 Aug; 
45(8):912–7. doi: 10.1038/ng.2676. Epub 2013 Jun 23. PubMed PMID: 
23793025. 
Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-
Rosich P, Winsvold B, Nyholt DR, van Oosterhout WP, Artto V, Todt U, 
Hämäläinen E, Fernández-Morales J, Louter MA, Kaunisto MA, Schoenen J, 
Raitakari O, Lehtimäki T, Vila-Pueyo M, Göbel H, Wichmann E, Sintas C, 
Uitterlinden AG, Hofman A, Rivadeneira F, Heinze A, Tronvik E, van Duijn 
CM, Kaprio J, Cormand B, Wessman M, Frants RR, Meitinger T, Müller-
Myhsok B, Zwart JA, Färkkilä M, Macaya A, Ferrari MD, Kubisch C, 
Palotie A, Dichgans M, van den Maagdenberg AM; International Headache 
Genetics Consortium. Genome-wide association analysis identifies sus-
ceptibility loci for migraine without aura. Nat Genet. 2012 Jun 
10;44(7):777–82. doi: 10.1038/ng.2307. PubMed PMID: 22683712. 
Saare M, Sõritsa D, Vaidla K, Palta P, Remm M, Laan M, Karro H, Sõritsa A, 
Salumets A, D'Hooghe T, Peters M. No evidence of somatic DNA copy 
number alterations in eutopic and ectopic endometrial tissue in 
endometriosis. Hum Reprod. 2012 Jun;27(6):1857–64.  
doi: 10.1093/humrep/des125. Epub 2012 Apr 3. PubMed PMID: 22473391. 
Clark C & Palta P, Joyce CJ, Scott C, Grundberg E, Deloukas P, Palotie A, 
Coffey AJ. A comparison of the whole genome approach of MeDIP-seq 
to the targeted approach of the Infinium HumanMethylation450 
BeadChip(®) for methylome profiling. PLoS One. 2012;7(11):e50233. 
doi: 0.1371/journal.pone.0050233. Epub 2012 Nov 29. PubMed PMID: 
23209683. 
Coffey AJ, Kokocinski F, Calafato MS, Scott CE, Palta P, Drury E, Joyce CJ, 
Leproust EM, Harrow J, Hunt S, Lehesjoki AE, Turner DJ, Hubbard TJ, 
Palotie A. The GENCODE exome: sequencing the complete human 
exome. Eur J Hum Genet. 2011 Jul;19(7):827–31.  
doi: 10.1038/ejhg.2011.28. Epub 2011 Mar 2. PubMed PMID: 21364695. 
Männik K, Parkel S, Palta P, Zilina O, Puusepp H, Esko T, Mägi R, Nõukas M, 
Veidenberg A, Nelis M, Metspalu A, Remm M, Ounap K, Kurg A. A 
parallel SNP array study of genomic aberrations associated with mental 
retardation in patients and general population in Estonia. Eur J Med 
Genet. 2011 Mar-Apr;54(2):136–43. doi: 10.1016/j.ejmg.2010.11.005. Epub 
2010 Nov 26. PubMed PMID: 21112420. 
Scheler O, Kaplinski L, Glynn B, Palta P, Parkel S, Toome K, Maher M, Barry 
T, Remm M, Kurg A. Detection of NASBA amplified bacterial tmRNA 
molecules on SLICSel designed microarray probes. BMC Biotechnol. 
2011 Feb 28;11:17. doi: 10.1186/1472-6750-11-17. PubMed PMID: 
21356118. 
108
 Kaplinski L, Scheler O, Parkel S, Palta P, Toome K, Kurg A, Remm M. 
Detection of tmRNA molecules on microarrays at low temperatures 
using helper oligonucleotides. BMC Biotechnol. 2010 Apr 28;10:34.  
doi: 10.1186/1472-6750-10-34. PubMed PMID: 20426847. 
Viltrop T, Krjutskov K, Palta P, Metspalu A. Comparison of DNA extraction 
methods for multiplex polymerase chain reaction. Anal Biochem. 2010 
Mar 15;398(2):260–2. doi: 10.1016/j.ab.2009.11.026. Epub 2009 Nov 20. 
PubMed PMID: 19932073. 
Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, 
Falchi M, Chen F, Andrieux J, Lobbens S, Delobel B, Stutzmann F, El-
Sayed Moustafa JS, Chèvre JC, Lecoeur C, Vatin V, Bouquillon S, Buxton 
JL, Boute O, Holder-Espinasse M, Cuisset JM, Lemaitre MP, Ambresin AE, 
Brioschi A, Gaillard M, Giusti V, Fellmann F, Ferrarini A, Hadjikhani N, 
Campion D, Guilmatre A, Goldenberg A, Calmels N, Mandel JL, Le 
Caignec C, David A, Isidor B, Cordier MP,  Dupuis-Girod S, Labalme A, 
Sanlaville D, Béri-Dexheimer M, Jonveaux P, Leheup B,  Ounap K, 
Bochukova EG, Henning E, Keogh J, Ellis RJ, Macdermot KD, van Haelst 
MM, Vincent-Delorme C, Plessis G, Touraine R, Philippe A, Malan V, 
Mathieu-Dramard M, Chiesa J, Blaumeiser B, Kooy RF, Caiazzo R, Pigeyre 
M, Balkau B, Sladek R, Bergmann S, Mooser V, Waterworth D, Reymond 
A, Vollenweider P, Waeber G, Kurg A, Palta P, Esko T, Metspalu A, Nelis 
M, Elliott P, Hartikainen AL, McCarthy MI, Peltonen L, Carlsson L, 
Jacobson P, Sjöström L, Huang N, Hurles ME, O'Rahilly S, Farooqi IS, 
Männik K, Jarvelin MR, Pattou F, Meyre D, Walley AJ, Coin LJ, lakemore 
AI, Froguel P, Beckmann JS. A new highly penetrant form of obesity due 
to deletions on chromosome 16p11.2. Nature. 2010 Feb 4;463(7281):671–
5. doi: 10.1038/nature08727. PubMed PMID: 20130649. 
Krjutskov K, Viltrop T, Palta P, Metspalu E, Tamm E, Suvi S, Sak K, Merilo A, 
Sork H, Teek R, Nikopensius T, Kivisild T, Metspalu A. Evaluation of the 
124-plex SNP typing microarray for forensic testing. Forensic Sci Int 
Genet. 2009 Dec;4(1):43–8. doi: 10.1016/j.fsigen.2009.04.007. Epub 2009 
May 15. PubMed PMID: 19948333. 
Scheler O, Glynn B, Parkel S, Palta P, Toome K, Kaplinski L, Remm M, Maher 
M, Kurg A. Fluorescent labeling of NASBA amplified tmRNA molecules 
for microarray applications. BMC Biotechnol. 2009 May 15;9:45.  
doi: 10.1186/1472-6750-9-45. PubMed PMID: 19445684. 
Kousoulidou L, Männik K, Zilina O, Parkel S, Palta P, Remm M, Kurg A, 
Patsalis PC. Application of two different microarray-based copy-number 
detection methodologies – array-comparative genomic hybridization 
and array-multiplex amplifiable probe hybridization – with identical 
amplifiable target sequences. Clin Chem Lab Med. 2008;46(5):722–4.  
doi: 10.1515/CCLM.2008.141. PubMed PMID: 18598207. 
Kousoulidou L, Männik K, Sismani C, Zilina O, Parkel S, Puusepp H, Tõnisson 
N, Palta P, Remm M, Kurg A, Patsalis PC. Array-MAPH: a methodology 
10928
for the detection of locus copy-number changes in complex genomes. Nat 
Protoc. 2008;3(5):849–65. doi: 10.1038/nprot.2008.49. PubMed PMID: 
18451793. 
Kousoulidou L, Parkel S, Zilina O, Palta P, Puusepp H, Remm M, Turner G, 
Boyle J, van Bokhoven H, de Brouwer A, Van Esch H, Froyen G, Ropers 
HH, Chelly J, Moraine C, Gecz J, Kurg A, Patsalis PC. Screening of 20 
patients with X-linked mental retardation using chromosome X-specific 
array-MAPH. Eur J Med Genet. 2007  Nov-Dec;50(6):399–410. Epub 2007 
Sep 29. PubMed PMID: 17980689. 
Patsalis PC, Kousoulidou L, Männik K, Sismani C, Zilina O, Parkel S, Puusepp  
H, Tõnisson N, Palta P, Remm M, Kurg A. Detection of small genomic 
imbalances using microarray-based multiplex amplifiable probe 
hybridization. Eur J Hum Genet. 2007 Feb;15(2):162–72. Epub 2006 Nov 
22. PubMed PMID: 17119536. 
 
Scholarships and awards: 
2013 Stipend of Finnish Cultural Foundation 
2007 Artur Lind’s stipend, Estonian Genome Foundation 
2007 Kristjan Jaak’s stipend, Archimedes Foundation 
 
Other scientific activities: 
Since 2012 Member of International Headache Society 
Since 2007 Member of the Estonian Society of Human Genetics 
 
Supervised dissertations: 
2008–2009 Andres Veidenberg, M.Sc., Department of Bioinformatics, 
Institute of Molecular and Cell Biology, University of Tartu 
2007–2008 Taavi Võsumaa (co-supervisor), M.Sc., Department of Bioinfor-
matics, Institute of Molecular and Cell Biology, University of 
Tartu 
2007–2008 Ksenia George, B.Sc., Department of Bioinformatics, Institute 
of Molecular and Cell Biology, University of Tartu 
 
  
110 
 ELULOOKIRJELDUS 
Nimi: Priit Palta 
Sünniaeg: 25. aprill, 1981 
Aadress: TÜ Molekulaar- ja Rakubioloogia Instituut, Riia 23, Tartu 
51010   
E-post: priit.palta@ut.ee 
Praegune töökoht: Teadur, Soome Molekulaarse Meditsiini Instituut (FIMM), 
Helsingi Ülikool 
 
Haridus: 
2007–2011 Ph.D. õpingud bioinformaatikas,  
Molekulaar- ja Rakubioloogia Instituut, Tartu Ülikool 
2005–2007 M.Sc. õpingud bioinformaatikas,  
Molekulaar- ja Rakubioloogia Instituut, Tartu Ülikool 
2000–2005 B.Sc. õpingud bioinformaatikas, Molekulaar- ja 
Rakubioloogia Instituut, Tartu Ülikool 
1994–2000 Tartu Mart Reiniku Gümnaasium 
1988–1994 Tartu 12. Keskkool 
 
Töökogemus: 
Alates 2013 Teadur, Soome Molekulaarse Meditsiini Instituut (FIMM), 
Helsingi Ülikool 
2011–2013 Külalisteadur, Wellcome Trust Sanger’i Instituut 
2007–2011 Teadur, Eesti Biokeskus 
2005–2007 Bioinformaatika spetsialist, Eesti Biokeskus 
2004–2008 Bioinformaatika spetsialist, Molekulaar- ja Rakubioloogia 
Instituut, Tartu Ülikool 
 
Peamised uurimisvaldkonnad: 
DNA koopiaarvu variandid ja nende seos haigustega, migreeni ja skisofreeniaga 
seotud mittesagedased geneetilised variandid ja kõrgenenud alleelisagedusega 
geneetilised variandid isoleeritud populatsioonides. 
 
Palta P, Kaplinski L, Nagirnaja L, Veid111
Publikatsioonide loetelu: 
Palta P, Kaplinski L, Nagirnaja L, Veidenberg A, Möls M, Esko T, Nelis M, 
Metspalu A, Laan M, Remm M. Haplotype phasing and inheritance of copy 
number variants in nuclear families. PLoS One. 2015;10(4):e0122713. doi: 
10.1371/journal.pone.0122713. PubMed PMID:25853576. 
Nagirnaja L, Palta P, Kasak L, Rull K, Christiansen OB, Nielsen HS, Steffensen 
R, Esko T, Remm M, Laan M. Structural genomic variation as risk factor 
for idiopathic recurrent miscarriage. Hum Mutat. 2014 Aug;35(8):972–82. 
doi: 10.1002/humu.22589. Epub 2014 Jun 24. PubMed PMID: 24827138. 
Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, Esko T, 
Mägi R, Inouye M, Lappalainen T, Chan Y, Salem RM, Lek M, Flannick J, 
Sim X, Manning A, Ladenvall C, Bumpstead S, Hämäläinen E, Aalto K, 
Maksimow M, Salmi M, Blankenberg S, Ardissino D, Shah S, Horne B, 
McPherson R, Hovingh GK, Reilly MP, Watkins H, Goel A, Farrall M, 
Girelli D, Reiner AP, Stitziel NO, Kathiresan S, Gabriel S, Barrett JC, 
Lehtimäki T, Laakso M, Groop L, Kaprio J, Perola M, McCarthy MI, 
Boehnke M, Altshuler DM, Lindgren CM, Hirschhorn JN, Metspalu A, 
Freimer NB, Zeller T, Jalkanen S, Koskinen S, Raitakari O, Durbin R, 
MacArthur DG, Salomaa V, Ripatti S, Daly MJ, Palotie A; Sequencing 
Initiative Suomi (SISu) Project. Distribution and Medical Impact of Loss-
of-Function Variants in the Finnish Founder Population. PLoS Genet. 
2014 Jul 31;10(7):e1004494. doi: 10.1371/journal.pgen.1004494. 
eCollection 2014 Jul. PubMed PMID: 25078778. 
Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, 
Georgieva L, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson 
JS, Roussos P, Barker DD, Banks E, Milanova V, Grant SG, Hannon E, 
Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, 
Palotie A, McCarroll SA, Holmans P, Sklar P, Owen MJ, Purcell SM, 
O’Donovan MC. De novo mutations in schizophrenia implicate synaptic 
networks. Nature. 2014 Feb 13;506(7487):179–84.  
doi: 10.1038/nature12929. Epub 2014 Jan 22. PubMed PMID: 24463507. 
Zilbauer M, Rayner TF, Clark C, Coffey AJ, Joyce CJ, Palta P, Palotie A, 
Lyons PA, Smith KG. Genome-wide methylation analyses of primary 
human leukocyte subsets identifies functionally important cell-type-
specific hypomethylated regions. Blood. 2013 Dec 12;122(25):e52–60.  
doi: 10.1182/blood-2013-05-503201. Epub 2013 Oct 24. PubMed PMID: 
24159175. 
Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, Kallela 
M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U, McArdle WL, 
Quaye L, Koiranen M, Ikram MA, Lehtimäki T, Stam AH, Ligthart L, 
Wedenoja J, Dunham I, Neale BM, Palta P, Hamalainen E, Schürks M, Rose 
LM, Buring JE, Ridker PM, Steinberg S, Stefansson H, Jakobsson F, Lawlor 
DA, Evans DM, Ring SM, Färkkilä M, Artto V, Kaunisto MA, Freilinger T, 
Schoenen J, Frants RR, Pelzer N, Weller CM, Zielman R, Heath AC, 
Madden PA, Montgomery GW, Martin NG, Borck G, Göbel H, Heinze A, 
Heinze-Kuhn K, Williams FM, Hartikainen AL, Pouta A, van den Ende J, 
Uitterlinden AG, Hofman A, Amin N, Hottenga JJ, Vink JM, Heikkilä K, 
Alexander M, Muller-Myhsok B, Schreiber S, Meitinger T, Wichmann HE, 
Aromaa A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E, Lage K, Jacobs 
SB, Gibbs JR, Birney E, Kaprio J, Penninx BW, Boomsma DI, van Duijn C, 
Raitakari O, Jarvelin MR, Zwart JA, Cherkas L, Strachan DP, Kubisch C, 
Ferrari MD, van den Maagdenberg AM, Dichgans M, Wessman M, Smith 
GD, Stefansson K, Daly MJ, Nyholt DR, Chasman DI, Palotie A; North 
112 
 American Brain Expression Consortium; UK Brain Expression Consortium; 
International Headache Genetics Consortium. Genome-wide meta-analysis 
identifies new susceptibility loci for migraine. Nat Genet. 2013 
Aug;45(8):912–7. doi: 10.1038/ng.2676. Epub 2013 Jun 23. PubMed PMID: 
23793025. 
Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-
Rosich P, Winsvold B, Nyholt DR, van Oosterhout WP, Artto V, Todt U, 
Hämäläinen E, Fernández-Morales J, Louter MA, Kaunisto MA, Schoenen J, 
Raitakari O, Lehtimäki T, Vila-Pueyo M, Göbel H, Wichmann E, Sintas C, 
Uitterlinden AG, Hofman A, Rivadeneira F, Heinze A, Tronvik E, van Duijn 
CM, Kaprio J, Cormand B, Wessman M, Frants RR, Meitinger T, Müller-
Myhsok B, Zwart JA, Färkkilä M, Macaya A, Ferrari MD, Kubisch C, 
Palotie A, Dichgans M, van den Maagdenberg AM; International Headache 
Genetics Consortium. Genome-wide association analysis identifies sus-
ceptibility loci for migraine without aura. Nat Genet. 2012 Jun 
10;44(7):777–82. doi: 10.1038/ng.2307. PubMed PMID: 22683712. 
Saare M, Sõritsa D, Vaidla K, Palta P, Remm M, Laan M, Karro H, Sõritsa A, 
Salumets A, D'Hooghe T, Peters M. No evidence of somatic DNA copy 
number alterations in eutopic and ectopic endometrial tissue in endo-
metriosis. Hum Reprod. 2012 Jun;27(6):1857–64. doi: 10.1093/humrep/ 
des125. Epub 2012 Apr 3. PubMed PMID: 22473391. 
Clark C & Palta P, Joyce CJ, Scott C, Grundberg E, Deloukas P, Palotie A, 
Coffey AJ. A comparison of the whole genome approach of MeDIP-seq 
to the targeted approach of the Infinium HumanMethylation450 
BeadChip(®) for methylome profiling. PLoS One. 2012;7(11):e50233. 
doi: 0.1371/journal.pone.0050233. Epub 2012 Nov 29. PubMed PMID: 
23209683. 
Coffey AJ, Kokocinski F, Calafato MS, Scott CE, Palta P, Drury E, Joyce CJ, 
Leproust EM, Harrow J, Hunt S, Lehesjoki AE, Turner DJ, Hubbard TJ, 
Palotie A. The GENCODE exome: sequencing the complete human 
exome. Eur J Hum Genet. 2011 Jul;19(7):827–31.  
doi: 10.1038/ejhg.2011.28. Epub 2011 Mar 2. PubMed PMID: 21364695. 
Männik K, Parkel S, Palta P, Zilina O, Puusepp H, Esko T, Mägi R, Nõukas M, 
Veidenberg A, Nelis M, Metspalu A, Remm M, Ounap K, Kurg A. A 
parallel SNP array study of genomic aberrations associated with mental 
retardation in patients and general population in Estonia. Eur J Med 
Genet. 2011 Mar-Apr;54(2):136–43. doi: 10.1016/j.ejmg.2010.11.005. Epub 
2010 Nov 26. PubMed PMID: 21112420. 
Scheler O, Kaplinski L, Glynn B, Palta P, Parkel S, Toome K, Maher M, Barry 
T, Remm M, Kurg A. Detection of NASBA amplified bacterial tmRNA 
molecules on SLICSel designed microarray probes. BMC Biotechnol. 
2011 Feb 28;11:17. doi: 10.1186/1472-6750-11-17. PubMed PMID: 
21356118. 
11329
Kaplinski L, Scheler O, Parkel S, Palta P, Toome K, Kurg A, Remm M. 
Detection of tmRNA molecules on microarrays at low temperatures 
using helper oligonucleotides. BMC Biotechnol. 2010 Apr 28;10:34. doi: 
10.1186/1472-6750-10-34. PubMed PMID: 20426847. 
Viltrop T, Krjutskov K, Palta P, Metspalu A. Comparison of DNA extraction 
methods for multiplex polymerase chain reaction. Anal Biochem. 2010 
Mar 15;398(2):260–2. doi: 10.1016/j.ab.2009.11.026. Epub 2009 Nov 20. 
PubMed PMID: 19932073. 
Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, 
Falchi M, Chen F, Andrieux J, Lobbens S, Delobel B, Stutzmann F, El-
Sayed Moustafa JS, Chèvre JC, Lecoeur C, Vatin V, Bouquillon S, Buxton 
JL, Boute O, Holder-Espinasse M, Cuisset JM, Lemaitre MP, Ambresin AE, 
Brioschi A, Gaillard M, Giusti V, Fellmann F, Ferrarini A, Hadjikhani N, 
Campion D, Guilmatre A, Goldenberg A, Calmels N, Mandel JL, Le 
Caignec C, David A, Isidor B, Cordier MP,  Dupuis-Girod S, Labalme A, 
Sanlaville D, Béri-Dexheimer M, Jonveaux P, Leheup B,  Ounap K, 
Bochukova EG, Henning E, Keogh J, Ellis RJ, Macdermot KD, van Haelst 
MM, Vincent-Delorme C, Plessis G, Touraine R, Philippe A, Malan V, 
Mathieu-Dramard M, Chiesa J, Blaumeiser B, Kooy RF, Caiazzo R, Pigeyre 
M, Balkau B, Sladek R, Bergmann S, Mooser V, Waterworth D, Reymond 
A, Vollenweider P, Waeber G, Kurg A, Palta P, Esko T, Metspalu A, Nelis 
M, Elliott P, Hartikainen AL, McCarthy MI, Peltonen L, Carlsson L, 
Jacobson P, Sjöström L, Huang N, Hurles ME, O'Rahilly S, Farooqi IS, 
Männik K, Jarvelin MR, Pattou F, Meyre D, Walley AJ, Coin LJ, lakemore 
AI, Froguel P, Beckmann JS. A new highly penetrant form of obesity due 
to deletions on chromosome 16p11.2. Nature. 2010 Feb 4;463(7281):671–
5. doi: 10.1038/nature08727. PubMed PMID: 20130649. 
Krjutskov K, Viltrop T, Palta P, Metspalu E, Tamm E, Suvi S, Sak K, Merilo A, 
Sork H, Teek R, Nikopensius T, Kivisild T, Metspalu A. Evaluation of the 
124-plex SNP typing microarray for forensic testing. Forensic Sci Int 
Genet. 2009 Dec;4(1):43–8. doi: 10.1016/j.fsigen.2009.04.007. Epub 2009 
May 15. PubMed PMID: 19948333. 
Scheler O, Glynn B, Parkel S, Palta P, Toome K, Kaplinski L, Remm M, Maher 
M, Kurg A. Fluorescent labeling of NASBA amplified tmRNA molecules 
for microarray applications. BMC Biotechnol. 2009 May 15;9:45. doi: 
10.1186/1472-6750-9-45. PubMed PMID: 19445684. 
Kousoulidou L, Männik K, Zilina O, Parkel S, Palta P, Remm M, Kurg A, 
Patsalis PC. Application of two different microarray-based copy-number 
detection methodologies – array-comparative genomic hybridization 
and array-multiplex amplifiable probe hybridization – with identical 
amplifiable target sequences. Clin Chem Lab Med. 2008;46(5):722–4. doi: 
10.1515/CCLM.2008.141. PubMed PMID: 18598207. 
Kousoulidou L, Männik K, Sismani C, Zilina O, Parkel S, Puusepp H, Tõnisson 
N, Palta P, Remm M, Kurg A, Patsalis PC. Array-MAPH: a methodology 
114 
for the detection of locus copy-number changes in complex genomes. Nat 
Protoc. 2008;3(5):849–65. doi: 10.1038/nprot.2008.49. PubMed PMID: 
18451793. 
Kousoulidou L, Parkel S, Zilina O, Palta P, Puusepp H, Remm M, Turner G, 
Boyle J, van Bokhoven H, de Brouwer A, Van Esch H, Froyen G, Ropers 
HH, Chelly J, Moraine C, Gecz J, Kurg A, Patsalis PC. Screening of 20 
patients with X-linked mental retardation using chromosome X-specific 
array-MAPH. Eur J Med Genet. 2007  Nov-Dec;50(6):399–410. Epub 2007 
Sep 29. PubMed PMID: 17980689. 
Patsalis PC, Kousoulidou L, Männik K, Sismani C, Zilina O, Parkel S, Puusepp  
H, Tõnisson N, Palta P, Remm M, Kurg A. Detection of small genomic 
imbalances using microarray-based multiplex amplifiable probe 
hybridization. Eur J Hum Genet. 2007 Feb;15(2):162–72. Epub 2006 Nov 
22. PubMed PMID: 17119536. 
 
Saadud stipendiumid: 
2013 Soome Kultuuri Sihtasutuse stipendium 
2007 Artur Linnu nimeline stipendium, Sihtasutus Geenikeskus 
2007 Kristjan Jaagu nimeline stipendium, Sihtasutus Archimedes 
 
Muu teaduslik organisatsiooniline ja erialane tegevus: 
Alates 2012 International Headache Society liige 
Alates 2007 Eesti Inimesegeneetika Ühingu liige 
 
Juhendatud väitekirjad: 
2008–2009 Andres Veidenberg, M.Sc., bioinformaatika õppetool, 
Molekulaar- ja Rakubioloogia Instituut, Tartu Ülikool 
2007–2008 Taavi Võsumaa (co-supervisor), M.Sc., bioinformaatika 
õppetool, Molekulaar- ja Rakubioloogia Instituut, Tartu Ülikool 
2007–2008 Ksenia George, B.Sc., bioinformaatika õppetool, Molekulaar- ja 
Rakubioloogia Instituut, Tartu Ülikool 
 
115 
116 
DISSERTATIONES BIOLOGICAE 
UNIVERSITATIS TARTUENSIS 
 
  1. Toivo Maimets. Studies of human oncoprotein p53. Tartu, 1991, 96 p. 
  2. Enn K. Seppet. Thyroid state control over energy metabolism, ion transport 
and contractile functions in rat heart. Tartu, 1991, 135 p.  
  3. Kristjan Zobel. Epifüütsete makrosamblike väärtus õhu saastuse indikaa-
toritena Hamar-Dobani boreaalsetes mägimetsades. Tartu, 1992, 131 lk. 
  4. Andres Mäe. Conjugal mobilization of catabolic plasmids by transposable 
elements in helper plasmids. Tartu, 1992, 91 p. 
  5. Maia Kivisaar. Studies on phenol degradation genes of Pseudomonas sp. 
strain EST 1001. Tartu, 1992, 61 p. 
  6. Allan Nurk. Nucleotide sequences of phenol degradative genes from 
Pseudomonas sp. strain EST 1001 and their transcriptional activation in 
Pseudomonas putida. Tartu, 1992, 72 p. 
  7. Ülo Tamm. The genus Populus L. in Estonia: variation of the species bio-
logy and introduction. Tartu, 1993, 91 p. 
  8. Jaanus Remme. Studies on the peptidyltransferase centre of the E.coli ribo-
some. Tartu, 1993, 68 p. 
  9. Ülo Langel. Galanin and galanin antagonists. Tartu, 1993, 97 p. 
10. Arvo Käärd. The development of an automatic online dynamic fluo-
rescense-based pH-dependent fiber optic penicillin flowthrought biosensor 
for the control of the benzylpenicillin hydrolysis. Tartu, 1993, 117 p. 
11. Lilian Järvekülg. Antigenic analysis and development of sensitive immu-
noassay for potato viruses. Tartu, 1993, 147 p. 
12. Jaak Palumets. Analysis of phytomass partition in Norway spruce. Tartu, 
1993, 47 p. 
13. Arne Sellin. Variation in hydraulic architecture of Picea abies (L.) Karst. 
trees grown under different enviromental conditions. Tartu, 1994, 119 p.  
13. Mati Reeben. Regulation of light neurofilament gene expression. Tartu, 
1994, 108 p. 
14. Urmas Tartes. Respiration rhytms in insects. Tartu, 1995, 109 p. 
15. Ülo Puurand. The complete nucleotide sequence and infections in vitro 
transcripts from cloned cDNA of a potato A potyvirus. Tartu, 1995, 96 p. 
16. Peeter Hõrak. Pathways of selection in avian reproduction: a functional 
framework and its application in the population study of the great tit (Parus 
major). Tartu, 1995, 118 p. 
17. Erkki Truve. Studies on specific and broad spectrum virus resistance in 
transgenic plants. Tartu, 1996, 158 p. 
18. Illar Pata. Cloning and characterization of human and mouse ribosomal 
protein S6-encoding genes. Tartu, 1996, 60 p. 
19. Ülo Niinemets. Importance of structural features of leaves and canopy in 
determining species shade-tolerance in temperature deciduous woody taxa. 
Tartu, 1996, 150 p. 
117 
20. Ants Kurg. Bovine leukemia virus: molecular studies on the packaging 
region and DNA diagnostics in cattle. Tartu, 1996, 104 p. 
21. Ene Ustav. E2 as the modulator of the BPV1 DNA replication. Tartu, 1996, 
100 p. 
22. Aksel Soosaar. Role of helix-loop-helix and nuclear hormone receptor tran-
scription factors in neurogenesis. Tartu, 1996, 109 p. 
23. Maido Remm. Human papillomavirus type 18: replication, transformation 
and gene expression. Tartu, 1997, 117 p. 
24. Tiiu Kull. Population dynamics in Cypripedium calceolus L. Tartu, 1997,  
124 p. 
25. Kalle Olli. Evolutionary life-strategies of autotrophic planktonic micro-
organisms in the Baltic Sea. Tartu, 1997, 180 p. 
26. Meelis Pärtel. Species diversity and community dynamics in calcareous 
grassland communities in Western Estonia. Tartu, 1997, 124 p. 
27. Malle Leht. The Genus Potentilla L. in Estonia, Latvia and Lithuania: dis-
tribution, morphology and taxonomy. Tartu, 1997, 186 p. 
28. Tanel Tenson. Ribosomes, peptides and antibiotic resistance. Tartu, 1997,  
80 p. 
29. Arvo Tuvikene. Assessment of inland water pollution using biomarker 
responses in fish in vivo and in vitro. Tartu, 1997, 160 p. 
30. Urmas Saarma. Tuning ribosomal elongation cycle by mutagenesis of  
23S rRNA. Tartu, 1997, 134 p. 
31. Henn Ojaveer. Composition and dynamics of fish stocks in the gulf of Riga 
ecosystem. Tartu, 1997, 138 p. 
32. Lembi Lõugas. Post-glacial development of vertebrate fauna in Estonian 
water bodies. Tartu, 1997, 138 p. 
33. Margus Pooga. Cell penetrating peptide, transportan, and its predecessors, 
galanin-based chimeric peptides. Tartu, 1998, 110 p. 
34. Andres Saag. Evolutionary relationships in some cetrarioid genera (Liche-
nized Ascomycota). Tartu, 1998, 196 p. 
35. Aivar Liiv. Ribosomal large subunit assembly in vivo. Tartu, 1998, 158 p. 
36. Tatjana Oja. Isoenzyme diversity and phylogenetic affinities among the 
eurasian annual bromes (Bromus L., Poaceae). Tartu, 1998, 92 p. 
37. Mari Moora. The influence of arbuscular mycorrhizal (AM) symbiosis on 
the competition and coexistence of calcareous grassland plant species. 
Tartu, 1998, 78 p. 
38. Olavi Kurina. Fungus gnats in Estonia (Diptera: Bolitophilidae, Keroplati-
dae, Macroceridae, Ditomyiidae, Diadocidiidae, Mycetophilidae). Tartu, 
1998, 200 p.  
39. Andrus Tasa. Biological leaching of shales: black shale and oil shale. 
Tartu, 1998, 98 p. 
40. Arnold Kristjuhan. Studies on transcriptional activator properties of tumor 
suppressor protein p53. Tartu, 1998, 86 p. 
30
118 
41. Sulev Ingerpuu. Characterization of some human myeloid cell surface and 
nuclear differentiation antigens. Tartu, 1998, 163 p. 
42. Veljo Kisand. Responses of planktonic bacteria to the abiotic and biotic 
factors in the shallow lake Võrtsjärv. Tartu, 1998, 118 p. 
43. Kadri Põldmaa. Studies in the systematics of hypomyces and allied genera 
(Hypocreales, Ascomycota). Tartu, 1998, 178 p. 
44. Markus Vetemaa. Reproduction parameters of fish as indicators in 
environmental monitoring. Tartu, 1998, 117 p. 
45. Heli Talvik. Prepatent periods and species composition of different 
Oesophagostomum spp. populations in Estonia and Denmark. Tartu, 1998, 
104 p. 
46. Katrin Heinsoo. Cuticular and stomatal antechamber conductance to water 
vapour diffusion in Picea abies (L.) karst. Tartu, 1999, 133 p. 
47. Tarmo Annilo. Studies on mammalian ribosomal protein S7. Tartu, 1998, 
77 p. 
48. Indrek Ots. Health state indicies of reproducing great tits (Parus major): 
sources of variation and connections with life-history traits. Tartu, 1999, 
117 p. 
49. Juan Jose Cantero. Plant community diversity and habitat relationships in 
central Argentina grasslands. Tartu, 1999, 161 p. 
50. Rein Kalamees. Seed bank, seed rain and community regeneration in 
Estonian calcareous grasslands. Tartu, 1999, 107 p. 
51. Sulev Kõks. Cholecystokinin (CCK) — induced anxiety in rats: influence 
of environmental stimuli and involvement of endopioid mechanisms and 
serotonin. Tartu, 1999, 123 p. 
52. Ebe Sild. Impact of increasing concentrations of O3 and CO2 on wheat, 
clover and pasture. Tartu, 1999, 123 p. 
53. Ljudmilla Timofejeva. Electron microscopical analysis of the synaptone-
mal complex formation in cereals. Tartu, 1999, 99 p. 
54. Andres Valkna. Interactions of galanin receptor with ligands and  
G-proteins: studies with synthetic peptides. Tartu, 1999, 103 p. 
55. Taavi Virro. Life cycles of planktonic rotifers in lake Peipsi. Tartu, 1999, 
101 p. 
56. Ana Rebane. Mammalian ribosomal protein S3a genes and intron-encoded 
small nucleolar RNAs U73 and U82. Tartu, 1999, 85 p. 
57. Tiina Tamm. Cocksfoot mottle virus: the genome organisation and transla-
tional strategies. Tartu, 2000,  101 p. 
58. Reet Kurg. Structure-function relationship of the bovine papilloma virus E2 
protein. Tartu, 2000, 89 p. 
59. Toomas Kivisild. The origins of Southern and Western Eurasian popula-
tions: an mtDNA study. Tartu, 2000, 121 p. 
60. Niilo Kaldalu. Studies of the TOL plasmid transcription factor XylS. Tartu 
2000. 88 p. 
119 
61. Dina Lepik. Modulation of viral DNA replication by tumor suppressor 
protein p53. Tartu 2000. 106 p. 
62. Kai Vellak. Influence of different factors on the diversity of the bryophyte 
vegetation in forest and wooded meadow communities. Tartu 2000. 122 p. 
63. Jonne Kotta. Impact of eutrophication and biological invasionas on the 
structure and functions of benthic macrofauna. Tartu 2000. 160 p. 
64. Georg Martin. Phytobenthic communities of the Gulf of Riga and the inner 
sea the West-Estonian archipelago. Tartu, 2000. 139 p. 
65.  Silvia Sepp. Morphological and genetical variation of Alchemilla L. in 
Estonia. Tartu, 2000. 124 p. 
66. Jaan Liira. On the determinants of structure and diversity in herbaceous 
plant communities. Tartu, 2000. 96 p. 
67. Priit Zingel. The role of planktonic ciliates in lake ecosystems. Tartu 2001. 
111 p. 
68. Tiit Teder. Direct and indirect effects in Host-parasitoid interactions: 
ecological and evolutionary consequences. Tartu 2001. 122 p. 
69. Hannes Kollist. Leaf apoplastic ascorbate as ozone scavenger and its 
transport across the plasma membrane. Tartu 2001. 80 p. 
70. Reet Marits. Role of two-component regulator system PehR-PehS and 
extracellular protease PrtW in virulence of Erwinia Carotovora subsp. 
Carotovora. Tartu 2001. 112 p. 
71. Vallo Tilgar. Effect of calcium supplementation on reproductive perfor-
mance of the pied flycatcher Ficedula hypoleuca and the great tit Parus 
major, breeding in Nothern temperate forests. Tartu, 2002. 126 p. 
72. Rita Hõrak. Regulation of transposition of transposon Tn4652 in 
Pseudomonas putida. Tartu, 2002. 108 p. 
73. Liina Eek-Piirsoo. The effect of fertilization, mowing and additional 
illumination on the structure of a species-rich grassland community. Tartu, 
2002. 74 p. 
74. Krõõt Aasamaa. Shoot hydraulic conductance and stomatal conductance of 
six temperate deciduous tree species. Tartu, 2002. 110 p. 
75. Nele Ingerpuu. Bryophyte diversity and vascular plants. Tartu, 2002. 
112 p. 
76. Neeme Tõnisson. Mutation detection by primer extension on oligo-
nucleotide microarrays. Tartu, 2002. 124 p. 
77. Margus Pensa. Variation in needle retention of Scots pine in relation to 
leaf morphology, nitrogen conservation and tree age. Tartu, 2003. 110 p. 
78. Asko Lõhmus. Habitat preferences and quality for birds of prey: from 
principles to applications. Tartu, 2003. 168 p. 
79. Viljar Jaks. p53 — a switch in cellular circuit. Tartu, 2003. 160 p. 
80. Jaana Männik. Characterization and genetic studies of four ATP-binding 
cassette (ABC) transporters. Tartu, 2003. 140 p. 
81. Marek Sammul. Competition and coexistence of clonal plants in relation to 
productivity. Tartu, 2003. 159 p 
120 
82. Ivar Ilves. Virus-cell interactions in the replication cycle of bovine 
papillomavirus type 1. Tartu, 2003. 89 p.  
83. Andres Männik. Design and characterization of a novel vector system 
based on the stable replicator of bovine papillomavirus type 1. Tartu, 2003. 
109 p. 
84. Ivika Ostonen. Fine root structure, dynamics and proportion in net 
primary production of Norway spruce forest ecosystem in relation to site 
conditions. Tartu, 2003. 158 p. 
85. Gudrun Veldre. Somatic status of 12–15-year-old Tartu schoolchildren. 
Tartu, 2003. 199 p. 
86.  Ülo Väli. The greater spotted eagle Aquila clanga and the lesser spotted 
eagle A. pomarina: taxonomy, phylogeography and ecology. Tartu, 2004. 
159 p.  
87. Aare Abroi. The determinants for the native activities of the bovine 
papillomavirus type 1 E2 protein are separable. Tartu, 2004. 135 p. 
88. Tiina Kahre. Cystic fibrosis in Estonia. Tartu, 2004. 116 p. 
89. Helen Orav-Kotta. Habitat choice and feeding activity of benthic suspension 
feeders and mesograzers in the northern Baltic Sea. Tartu, 2004. 117 p. 
90. Maarja Öpik. Diversity of arbuscular mycorrhizal fungi in the roots of 
perennial plants and their effect on plant performance. Tartu, 2004. 175 p.  
91. Kadri Tali. Species structure of Neotinea ustulata. Tartu, 2004. 109 p. 
92. Kristiina Tambets. Towards the understanding of post-glacial spread of 
human mitochondrial DNA haplogroups in Europe and beyond: a phylo-
geographic approach. Tartu, 2004. 163 p. 
93. Arvi Jõers. Regulation of p53-dependent transcription. Tartu, 2004. 103 p. 
94. Lilian Kadaja. Studies on modulation of the activity of tumor suppressor 
protein p53. Tartu, 2004. 103 p. 
95. Jaak Truu. Oil shale industry wastewater: impact on river microbial  
community and possibilities for bioremediation. Tartu, 2004. 128 p. 
96. Maire Peters. Natural horizontal transfer of the pheBA operon. Tartu, 
2004. 105 p. 
97. Ülo Maiväli. Studies on the structure-function relationship of the bacterial 
ribosome. Tartu, 2004. 130 p.  
98. Merit Otsus. Plant community regeneration and species diversity in dry 
calcareous grasslands. Tartu, 2004. 103 p. 
99. Mikk Heidemaa. Systematic  studies  on  sawflies of  the  genera Dolerus,  
Empria,  and  Caliroa (Hymenoptera:  Tenthredinidae). Tartu, 2004. 167 p. 
100. Ilmar Tõnno. The impact of nitrogen and phosphorus concentration and 
N/P ratio on cyanobacterial dominance and N2 fixation in some Estonian 
lakes. Tartu, 2004. 111 p. 
101. Lauri Saks. Immune function, parasites, and carotenoid-based ornaments 
in greenfinches. Tartu, 2004. 144 p.  
102. Siiri Rootsi. Human Y-chromosomal variation in European populations. 
Tartu, 2004. 142 p. 
121 
103. Eve Vedler. Structure of the 2,4-dichloro-phenoxyacetic acid-degradative 
plasmid pEST4011. Tartu, 2005. 106 p.  
104.  Andres Tover. Regulation of transcription of the phenol degradation 
pheBA operon in Pseudomonas putida. Tartu, 2005. 126 p. 
105.  Helen Udras. Hexose  kinases  and  glucose transport  in  the  yeast Han-
senula  polymorpha. Tartu, 2005. 100 p. 
106. Ave Suija. Lichens and lichenicolous fungi in Estonia: diversity, distri-
bution patterns, taxonomy. Tartu, 2005. 162 p. 
107. Piret Lõhmus. Forest lichens and their substrata in Estonia. Tartu, 2005. 
162 p.  
108. Inga Lips. Abiotic factors controlling the cyanobacterial bloom occur-
rence in the Gulf of Finland. Tartu, 2005. 156 p. 
109.  Kaasik, Krista. Circadian clock genes in mammalian clockwork, meta-
bolism and behaviour. Tartu, 2005. 121 p. 
110.  Juhan Javoiš. The effects of experience on host acceptance in ovipositing 
moths. Tartu, 2005. 112 p.  
111.  Tiina Sedman. Characterization  of  the  yeast Saccharomyces  cerevisiae 
mitochondrial  DNA  helicase  Hmi1. Tartu, 2005. 103 p.  
112.  Ruth Aguraiuja. Hawaiian endemic fern lineage Diellia (Aspleniaceae): 
distribution, population structure and ecology. Tartu, 2005. 112 p.  
113.  Riho Teras. Regulation of transcription from the fusion promoters ge-
nerated by transposition of Tn4652 into the upstream region of pheBA 
operon in Pseudomonas putida. Tartu, 2005. 106 p.  
114.  Mait Metspalu. Through the course of prehistory in india: tracing the 
mtDNA trail. Tartu, 2005. 138 p.  
115. Elin Lõhmussaar. The comparative patterns of linkage disequilibrium in 
European populations and its implication for genetic association studies. 
Tartu, 2006. 124 p. 
116. Priit Kupper. Hydraulic and environmental limitations to leaf water rela-
tions in trees with respect to canopy position. Tartu, 2006. 126 p. 
117. Heili Ilves. Stress-induced transposition of Tn4652 in Pseudomonas 
Putida. Tartu, 2006. 120 p. 
118. Silja Kuusk. Biochemical properties of Hmi1p, a DNA helicase from 
Saccharomyces cerevisiae mitochondria. Tartu, 2006. 126 p. 
119. Kersti Püssa. Forest edges on medium resolution landsat thematic mapper 
satellite images. Tartu, 2006. 90 p. 
120. Lea Tummeleht. Physiological condition and immune function in great 
tits (Parus major l.): Sources of variation and trade-offs in relation to 
growth. Tartu, 2006. 94 p. 
121. Toomas Esperk. Larval instar as a key element of insect growth schedules. 
Tartu, 2006. 186 p.  
122. Harri Valdmann. Lynx (Lynx lynx) and wolf (Canis lupus)  in the Baltic 
region:  Diets,  helminth parasites and genetic variation. Tartu, 2006. 102 p. 
31
122 
123. Priit Jõers. Studies of the mitochondrial helicase Hmi1p in Candida 
albicans and Saccharomyces cerevisia. Tartu, 2006. 113 p. 
124. Kersti Lilleväli. Gata3 and Gata2 in inner ear development. Tartu, 2007. 
123 p.  
125. Kai Rünk. Comparative ecology of three fern species: Dryopteris carthu-
siana (Vill.) H.P. Fuchs, D. expansa (C. Presl) Fraser-Jenkins & Jermy and 
D. dilatata (Hoffm.) A. Gray (Dryopteridaceae). Tartu, 2007. 143 p.  
126. Aveliina Helm. Formation and persistence of dry grassland diversity: role 
of human history and landscape structure. Tartu, 2007. 89 p.  
127. Leho Tedersoo. Ectomycorrhizal fungi: diversity and community structure 
in Estonia, Seychelles and Australia. Tartu, 2007. 233 p.  
128. Marko Mägi. The habitat-related variation of reproductive performance of 
great tits in a deciduous-coniferous forest mosaic: looking for causes and 
consequences. Tartu, 2007. 135 p.  
129. Valeria Lulla. Replication strategies and applications of Semliki Forest 
virus. Tartu, 2007. 109 p.  
130. Ülle Reier. Estonian threatened vascular plant species: causes of rarity and 
conservation. Tartu, 2007. 79 p. 
131. Inga Jüriado. Diversity of lichen species in Estonia: influence of regional 
and local factors. Tartu, 2007. 171 p. 
132. Tatjana Krama. Mobbing behaviour in birds: costs and reciprocity based 
cooperation. Tartu, 2007. 112 p. 
133. Signe Saumaa. The role of DNA mismatch repair and oxidative DNA 
damage defense systems in avoidance of stationary phase mutations in 
Pseudomonas putida. Tartu, 2007. 172 p. 
134. Reedik Mägi. The linkage disequilibrium and the selection of genetic 
markers for association studies in european populations. Tartu, 2007. 96 p.  
135. Priit Kilgas. Blood parameters as indicators of physiological condition and 
skeletal development in great tits (Parus major): natural variation and 
application in the reproductive ecology of birds. Tartu, 2007. 129 p.  
136. Anu Albert. The role of water salinity in structuring eastern Baltic coastal 
fish communities. Tartu, 2007. 95 p.  
137. Kärt Padari. Protein transduction mechanisms of transportans. Tartu, 2008. 
128 p. 
138. Siiri-Lii Sandre. Selective forces on larval colouration in a moth. Tartu, 
2008. 125 p. 
139. Ülle Jõgar. Conservation and restoration of semi-natural floodplain mea-
dows and their rare plant species. Tartu, 2008. 99 p. 
140. Lauri Laanisto. Macroecological approach in vegetation science: gene-
rality of ecological relationships at the global scale. Tartu, 2008. 133 p. 
141. Reidar Andreson. Methods and software for predicting PCR failure rate in 
large genomes. Tartu, 2008. 105 p.  
142. Birgot Paavel. Bio-optical properties of turbid lakes. Tartu, 2008. 175 p. 
123 
143. Kaire Torn. Distribution and ecology of charophytes in the Baltic Sea. 
Tartu, 2008, 98 p.  
144. Vladimir Vimberg. Peptide mediated macrolide resistance. Tartu, 2008, 
190 p. 
145. Daima Örd. Studies on the stress-inducible pseudokinase TRB3, a novel 
inhibitor of transcription factor ATF4. Tartu, 2008, 108 p. 
146. Lauri Saag. Taxonomic and ecologic problems in the genus Lepraria 
(Stereocaulaceae, lichenised Ascomycota). Tartu, 2008, 175 p. 
147. Ulvi Karu. Antioxidant protection, carotenoids and coccidians in green-
finches – assessment of the costs of immune activation and mechanisms of 
parasite resistance in a passerine with carotenoid-based ornaments. Tartu, 
2008, 124 p. 
148. Jaanus Remm. Tree-cavities in forests: density, characteristics and occu-
pancy by animals. Tartu, 2008, 128 p. 
149. Epp Moks. Tapeworm parasites Echinococcus multilocularis and E. gra-
nulosus in Estonia: phylogenetic relationships and occurrence in wild 
carnivores and ungulates. Tartu, 2008, 82 p. 
150. Eve Eensalu. Acclimation of stomatal structure and function in tree ca-
nopy: effect of light and CO2 concentration. Tartu, 2008, 108 p. 
151. Janne Pullat. Design, functionlization and application of an in situ 
synthesized oligonucleotide microarray. Tartu, 2008, 108 p. 
152. Marta Putrinš. Responses of Pseudomonas putida to phenol-induced 
metabolic and stress signals. Tartu, 2008, 142 p.  
153.  Marina Semtšenko. Plant root behaviour: responses to neighbours and 
physical obstructions. Tartu, 2008, 106 p. 
154. Marge Starast. Influence of cultivation techniques on productivity and 
fruit quality of some Vaccinium and Rubus taxa. Tartu, 2008, 154 p.  
155. Age Tats. Sequence motifs influencing the efficiency of translation. Tartu, 
2009, 104 p. 
156. Radi Tegova. The role of specialized DNA polymerases in mutagenesis in 
Pseudomonas putida. Tartu, 2009, 124 p. 
157. Tsipe Aavik. Plant species richness, composition and functional trait 
pattern in agricultural landscapes – the role of land use intensity and land-
scape structure. Tartu, 2009, 112 p. 
158. Kaja Kiiver. Semliki forest virus based vectors and cell lines for studying 
the replication and interactions of alphaviruses and hepaciviruses. Tartu, 
2009, 104 p. 
159. Meelis Kadaja. Papillomavirus Replication Machinery Induces Genomic 
Instability in its Host Cell. Tartu, 2009, 126 p. 
160. Pille Hallast. Human and chimpanzee Luteinizing hormone/Chorionic 
Gonadotropin beta (LHB/CGB) gene clusters: diversity and divergence of 
young duplicated genes. Tartu, 2009, 168 p. 
161. Ain Vellak. Spatial and temporal aspects of plant species conservation. 
Tartu, 2009, 86 p. 
124 
162. Triinu Remmel. Body size evolution in insects with different colouration 
strategies: the role of predation risk. Tartu, 2009, 168 p. 
163. Jaana Salujõe. Zooplankton as the indicator of ecological quality and fish 
predation in lake ecosystems. Tartu, 2009, 129 p. 
164. Ele Vahtmäe. Mapping benthic habitat with remote sensing in optically 
complex coastal environments. Tartu, 2009, 109 p.  
165. Liisa Metsamaa. Model-based assessment to improve the use of remote 
sensing in recognition and quantitative mapping of cyanobacteria. Tartu, 
2009, 114 p. 
166. Pille Säälik. The role of endocytosis in the protein transduction by cell-
penetrating peptides. Tartu, 2009, 155 p. 
167. Lauri Peil. Ribosome assembly factors in Escherichia coli. Tartu, 2009,  
147 p. 
168. Lea Hallik. Generality and specificity in light harvesting, carbon gain 
capacity and shade tolerance among plant functional groups. Tartu, 2009, 
99 p. 
169. Mariliis Tark. Mutagenic potential of DNA damage repair and tolerance 
mechanisms under starvation stress. Tartu, 2009, 191 p. 
170. Riinu Rannap. Impacts of habitat loss and restoration on amphibian po-
pulations. Tartu, 2009, 117 p. 
171. Maarja Adojaan. Molecular variation of HIV-1 and the use of this know-
ledge in vaccine development. Tartu, 2009, 95 p. 
172. Signe Altmäe. Genomics and transcriptomics of human induced ovarian 
folliculogenesis. Tartu, 2010, 179 p. 
173. Triin Suvi. Mycorrhizal fungi of native and introduced trees in the 
Seychelles Islands. Tartu, 2010, 107 p. 
174. Velda Lauringson. Role of suspension feeding in a brackish-water coastal 
sea. Tartu, 2010, 123 p. 
175. Eero Talts. Photosynthetic cyclic electron transport – measurement and 
variably proton-coupled mechanism. Tartu, 2010, 121 p.  
176. Mari Nelis. Genetic structure of the Estonian population and genetic 
distance from other populations of European descent. Tartu, 2010, 97 p. 
177. Kaarel Krjutškov. Arrayed Primer Extension-2 as a multiplex PCR-based 
method for nucleic acid variation analysis: method and applications. Tartu, 
2010, 129 p. 
178. Egle Köster. Morphological and genetical variation within species complexes: 
Anthyllis vulneraria s. l. and Alchemilla vulgaris (coll.). Tartu, 2010, 101 p. 
179. Erki Õunap. Systematic studies on the subfamily Sterrhinae (Lepidoptera: 
Geometridae). Tartu, 2010, 111 p.  
180. Merike Jõesaar. Diversity of key catabolic genes at degradation of phenol 
and p-cresol in pseudomonads. Tartu, 2010, 125 p. 
181. Kristjan Herkül. Effects of physical disturbance and habitat-modifying 
species on sediment properties and benthic communities in the northern 
Baltic Sea. Tartu, 2010, 123 p. 
125 
182. Arto Pulk. Studies on bacterial ribosomes by chemical modification 
approaches. Tartu, 2010, 161 p. 
183. Maria Põllupüü. Ecological relations of cladocerans in a brackish-water 
ecosystem. Tartu, 2010, 126 p.  
184. Toomas Silla. Study of the segregation mechanism of the Bovine 
Papillomavirus Type 1. Tartu, 2010, 188 p. 
185. Gyaneshwer Chaubey. The demographic history of India: A perspective 
based on genetic evidence. Tartu, 2010, 184 p. 
186. Katrin Kepp. Genes involved in cardiovascular traits: detection of genetic 
variation in Estonian and Czech populations. Tartu, 2010, 164 p. 
187. Virve Sõber. The role of biotic interactions in plant reproductive per-
formance. Tartu, 2010, 92 p. 
188. Kersti Kangro. The response of phytoplankton community to the changes 
in nutrient loading. Tartu, 2010, 144 p. 
189. Joachim M. Gerhold. Replication and Recombination of mitochondrial 
DNA in Yeast. Tartu, 2010, 120 p. 
190. Helen Tammert. Ecological role of physiological and phylogenetic 
diversity in aquatic bacterial communities. Tartu, 2010, 140 p. 
191. Elle Rajandu. Factors determining plant and lichen species diversity and 
composition in Estonian Calamagrostis and Hepatica site type forests. 
Tartu, 2010, 123 p. 
192. Paula Ann Kivistik. ColR-ColS signalling system and transposition of 
Tn4652 in the adaptation of Pseudomonas putida. Tartu, 2010, 118 p. 
193. Siim Sõber. Blood pressure genetics: from candidate genes to genome-
wide association studies. Tartu, 2011, 120 p. 
194. Kalle Kipper. Studies on the role of helix 69 of 23S rRNA in the factor-
dependent stages of translation initiation, elongation, and termination. 
Tartu, 2011, 178 p. 
195. Triinu Siibak. Effect of antibiotics on ribosome assembly is indirect. 
Tartu, 2011, 134 p. 
196. Tambet Tõnissoo. Identification and molecular analysis of the role of 
guanine nucleotide exchange factor RIC-8 in mouse development and 
neural function. Tartu, 2011, 110 p. 
197. Helin Räägel. Multiple faces of cell-penetrating peptides – their intra-
cellular trafficking, stability and endosomal escape during protein trans-
duction. Tartu, 2011, 161 p.  
198. Andres Jaanus. Phytoplankton in Estonian coastal waters – variability, 
trends and response to environmental pressures. Tartu, 2011, 157 p. 
199. Tiit Nikopensius. Genetic predisposition to nonsyndromic orofacial clefts. 
Tartu, 2011, 152 p. 
200. Signe Värv. Studies on the mechanisms of RNA polymerase II-dependent 
transcription elongation. Tartu, 2011, 108 p. 
201. Kristjan Välk. Gene expression profiling and genome-wide association 
studies of non-small cell lung cancer. Tartu, 2011, 98 p. 
32
126 
202. Arno Põllumäe. Spatio-temporal patterns of native and invasive zoo-
plankton species under changing climate and eutrophication conditions. 
Tartu, 2011, 153 p. 
203. Egle Tammeleht. Brown bear (Ursus arctos) population structure, demo-
graphic processes and variations in diet in northern Eurasia. Tartu, 2011, 
143 p.  
205. Teele Jairus. Species composition and host preference among ectomy-
corrhizal fungi in Australian and African ecosystems. Tartu, 2011, 106 p.   
206. Kessy Abarenkov. PlutoF – cloud database and computing services 
supporting biological research. Tartu, 2011, 125 p.  
207. Marina Grigorova. Fine-scale genetic variation of follicle-stimulating 
hormone beta-subunit coding gene (FSHB) and its association with repro-
ductive health. Tartu, 2011, 184 p. 
208. Anu Tiitsaar. The effects of predation risk and habitat history on butterfly 
communities. Tartu, 2011, 97 p. 
209. Elin Sild. Oxidative defences in immunoecological context: validation and 
application of assays for nitric oxide production and oxidative burst in a 
wild passerine. Tartu, 2011, 105 p. 
210. Irja Saar. The taxonomy and phylogeny of the genera Cystoderma and 
Cystodermella (Agaricales, Fungi). Tartu, 2012, 167 p. 
211. Pauli Saag. Natural variation in plumage bacterial assemblages in two 
wild breeding passerines. Tartu, 2012, 113 p. 
212. Aleksei Lulla. Alphaviral nonstructural protease and its polyprotein 
substrate: arrangements for the perfect marriage. Tartu, 2012, 143 p. 
213. Mari Järve. Different genetic perspectives on human history in Europe 
and the Caucasus: the stories told by uniparental and autosomal markers. 
Tartu, 2012, 119 p. 
214. Ott Scheler. The application of tmRNA as a marker molecule in bacterial 
diagnostics using microarray and biosensor technology. Tartu, 2012, 93 p. 
215. Anna Balikova. Studies on the functions of tumor-associated mucin-like 
leukosialin (CD43) in human cancer cells. Tartu, 2012, 129 p. 
216. Triinu Kõressaar. Improvement of PCR primer design for detection of 
prokaryotic species. Tartu, 2012, 83 p. 
217. Tuul Sepp. Hematological health state indices of greenfinches: sources of 
individual variation and responses to immune system manipulation. Tartu, 
2012, 117 p. 
218. Rya Ero. Modifier view of the bacterial ribosome. Tartu, 2012, 146 p. 
219. Mohammad Bahram. Biogeography of ectomycorrhizal fungi across dif-
ferent spatial scales. Tartu, 2012, 165 p. 
220. Annely Lorents. Overcoming the plasma membrane barrier: uptake of 
amphipathic cell-penetrating peptides induces influx of calcium ions and 
downstream responses. Tartu, 2012, 113 p. 
127 
221. Katrin Männik. Exploring the genomics of cognitive impairment: whole-
genome SNP genotyping experience in Estonian patients and general 
population. Tartu, 2012, 171 p. 
222. Marko Prous. Taxonomy and phylogeny of the sawfly genus Empria 
(Hymenoptera, Tenthredinidae). Tartu, 2012, 192 p. 
223. Triinu Visnapuu. Levansucrases encoded in the genome of Pseudomonas 
syringae pv. tomato DC3000: heterologous expression, biochemical 
characterization, mutational analysis and spectrum of polymerization 
products. Tartu, 2012, 160 p. 
224. Nele Tamberg. Studies on Semliki Forest virus replication and patho-
genesis. Tartu, 2012, 109 p. 
225. Tõnu Esko. Novel applications of SNP array data in the analysis of the ge-
netic structure of Europeans and in genetic association studies. Tartu, 
2012, 149 p. 
226. Timo Arula. Ecology of early life-history stages of herring Clupea 
harengus membras in the northeastern Baltic Sea. Tartu, 2012, 143 p. 
227. Inga Hiiesalu. Belowground plant diversity and coexistence patterns in 
grassland ecosystems. Tartu, 2012, 130 p. 
228. Kadri Koorem. The influence of abiotic and biotic factors on small-scale 
plant community patterns and regeneration in boreonemoral forest. Tartu, 
2012, 114 p.  
229. Liis Andresen. Regulation of virulence in plant-pathogenic pectobacteria. 
Tartu, 2012, 122 p. 
230. Kaupo Kohv. The direct and indirect effects of management on boreal 
forest structure and field layer vegetation. Tartu, 2012, 124 p. 
231. Mart Jüssi. Living on an edge: landlocked seals in changing climate. 
Tartu, 2012, 114 p. 
232. Riina Klais. Phytoplankton trends in the Baltic Sea. Tartu, 2012, 136 p. 
233. Rauno Veeroja. Effects of winter weather, population density and timing 
of reproduction on life-history traits and population dynamics of moose 
(Alces alces) in Estonia. Tartu, 2012, 92 p.  
234. Marju Keis. Brown bear (Ursus arctos) phylogeography in northern 
Eurasia. Tartu, 2013, 142 p.  
235. Sergei Põlme. Biogeography and ecology of alnus- associated ecto-
mycorrhizal fungi – from regional to global scale. Tartu, 2013, 90 p. 
236. Liis Uusküla. Placental gene expression in normal and complicated 
pregnancy. Tartu, 2013, 173 p. 
237. Marko Lõoke. Studies on DNA replication initiation in Saccharomyces 
cerevisiae. Tartu, 2013, 112 p. 
238. Anne Aan. Light- and nitrogen-use and biomass allocation along pro-
ductivity gradients in multilayer plant communities. Tartu, 2013, 127 p.   
239. Heidi Tamm. Comprehending phylogenetic diversity – case studies in 
three groups of ascomycetes. Tartu, 2013, 136 p.  
128 
240. Liina Kangur. High-Pressure Spectroscopy Study of Chromophore-
Binding Hydrogen Bonds in Light-Harvesting Complexes of Photo-
synthetic Bacteria. Tartu, 2013, 150 p.  
241. Margus Leppik. Substrate specificity of the multisite specific pseudo-
uridine synthase RluD. Tartu, 2013, 111 p. 
242. Lauris Kaplinski. The application of oligonucleotide hybridization model 
for PCR and microarray optimization. Tartu, 2013, 103 p. 
243. Merli Pärnoja. Patterns of macrophyte distribution and productivity in 
coastal ecosystems: effect of abiotic and biotic forcing. Tartu, 2013, 155 p. 
244. Tõnu Margus. Distribution and phylogeny of the bacterial translational 
GTPases and the Mqsr/YgiT regulatory system. Tartu, 2013, 126 p. 
245. Pille Mänd. Light use capacity and carbon and nitrogen budget of plants: 
remote assessment and physiological determinants. Tartu, 2013, 128 p.  
246. Mario Plaas. Animal model of Wolfram Syndrome in mice: behavioural, 
biochemical and psychopharmacological characterization. Tartu, 2013,  
144 p.  
247. Georgi Hudjašov. Maps of mitochondrial DNA, Y-chromosome and tyro-
sinase variation in Eurasian and Oceanian populations. Tartu, 2013,  
115 p. 
248.  Mari Lepik. Plasticity to light in herbaceous plants and its importance for 
community structure and diversity. Tartu, 2013, 102 p. 
249. Ede Leppik. Diversity of lichens in semi-natural habitats of Estonia. 
Tartu, 2013, 151 p.  
250. Ülle Saks. Arbuscular mycorrhizal fungal diversity patterns in boreo-
nemoral forest ecosystems. Tartu, 2013, 151 p.  
251.  Eneli Oitmaa. Development of arrayed primer extension microarray 
assays for molecular diagnostic applications. Tartu, 2013, 147 p. 
252. Jekaterina Jutkina. The horizontal gene pool for aromatics degradation: 
bacterial catabolic plasmids of the Baltic Sea aquatic system. Tartu, 2013, 
121 p. 
253. Helen Vellau. Reaction norms for size and age at maturity in insects: rules 
and exceptions. Tartu, 2014, 132 p.  
254. Randel Kreitsberg. Using biomarkers in assessment of environmental 
contamination in fish – new perspectives. Tartu, 2014, 107 p.  
255. Krista Takkis. Changes in plant species richness and population per-
formance in response to habitat loss and fragmentation.Tartu, 2014, 141 p. 
256. Liina Nagirnaja. Global and fine-scale genetic determinants of recurrent 
pregnancy loss. Tartu, 2014, 211 p.  
257. Triin Triisberg. Factors influencing the re-vegetation of abandoned 
extracted peatlands in Estonia. Tartu, 2014, 133 p. 
258. Villu Soon. A phylogenetic revision of the Chrysis ignita species group 
(Hymenoptera: Chrysididae) with emphasis on the northern European 
fauna. Tartu, 2014, 211 p. 
129 
259. Andrei Nikonov. RNA-Dependent RNA Polymerase Activity as a Basis 
for the Detection of Positive-Strand RNA Viruses by Vertebrate Host 
Cells. Tartu, 2014, 207 p. 
260. Eele Õunapuu-Pikas. Spatio-temporal variability of leaf hydraulic con-
ductance in woody plants: ecophysiological consequences. Tartu, 2014, 
135 p.  
261. Marju Männiste. Physiological ecology of greenfinches: information con-
tent of feathers in relation to immune function and behavior. Tartu, 2014, 
121 p. 
262. Katre Kets. Effects of elevated concentrations of CO2 and O3 on leaf 
photosynthetic parameters in Populus tremuloides: diurnal, seasonal and 
interannual patterns. Tartu, 2014, 115 p. 
263. Külli Lokko. Seasonal and spatial variability of zoopsammon commu-
nities in relation to environmental parameters. Tartu, 2014, 129 p.  
264. Olga Žilina. Chromosomal microarray analysis as diagnostic tool: 
Estonian experience. Tartu, 2014, 152 p.  
265. Kertu Lõhmus. Colonisation ecology of forest-dwelling vascular plants 
and the conservation value of rural manor parks. Tartu, 2014, 111 p. 
266. Anu Aun. Mitochondria as integral modulators of cellular signaling. Tartu, 
2014, 167 p.  
267. Chandana Basu Mallick. Genetics of adaptive traits and gender-specific 
demographic processes in South Asian populations. Tartu, 2014, 160 p. 
268.  Riin Tamme. The relationship between small-scale environmental hetero-
geneity and plant species diversity. Tartu, 2014, 130 p. 
269. Liina Remm. Impacts of forest drainage on biodiversity and habitat 
quality: implications for sustainable management and conservation. Tartu, 
2015, 126 p.  
270. Tiina Talve. Genetic diversity and taxonomy within the genus Rhinanthus. 
Tartu, 2015, 106 p. 
271. Mehis Rohtla. Otolith sclerochronological studies on migrations, spawning 
habitat preferences and age of freshwater fishes inhabiting the Baltic Sea. 
Tartu, 2015, 137 p. 
272. Alexey Reshchikov. The world fauna of the genus Lathrolestes (Hyme-
noptera, Ichneumonidae). Tartu, 2015, 247 p. 
273. Martin Pook. Studies on artificial and extracellular matrix protein-rich 
surfaces as regulators of cell growth and differentiation. Tartu, 2015, 142 p. 
274. Mai Kukumägi. Factors affecting soil respiration and its components in 
silver birch and Norway spruce stands. Tartu, 2015, 155 p. 
275. Helen Karu. Development of ecosystems under human activity in the 
North-East Estonian industrial region: forests on post-mining sites and 
bogs. Tartu, 2015, 152 p. 
276. Hedi Peterson. Exploiting high-throughput data for establishing relation-
ships between genes. Tartu, 2015, 186 p. 
 
33
277.  Priit Adler. Analysis and visualisation of large scale microarray data, 
Tartu, 2015, 126 p.  
278.  Aigar Niglas. Effects of environmental factors on gas exchange in 
deciduous trees: focus on photosynthetic water-use efficiency. Tartu, 2015, 
152 p.  
279. Silja Laht. Classification and identification of conopeptides using profile 
hidden Markov models and position-specific scoring matrices. Tartu, 2015, 
100 p. 
280.  Martin Kesler. Biological characteristics and restoration of Atlantic 
salmon Salmo salar populations in the Rivers of Northern Estonia. Tartu, 
2015, 97 p. 
281. Pratyush Kumar Das. Biochemical perspective on alphaviral nonstruc-
tural protein 2: a tale from multiple domains to enzymatic profiling. Tartu, 
2015, 205 p 
 
 
 
